Asthma mixed form (mode)

ASTHMA_MIXED

asthma: A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors resulting in recurring periods of wheezing (a whistling sound while breathing), chest tightness, shortness of breath, mucus production and coughing. The symptoms appear due to a variety of triggers such as allergens, irritants, respiratory infections, weather changes, exercise, stress, reflux disease, medications, foods and emotional anxiety.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Check mode of ICD-10 codes: %J458 Registry filters: Hospital discharge: ICD-10 — J45.8 Cause of death: ICD-10 — J45.8 2 out of 7 registries used, show all original rules.	2667
4. Check minimum number of events None	2667
5. Include endpoints None	2667
6. Filter based on genotype QC (FinnGen only)	2415

Control definitions (FinnGen only)

Control exclude: J10_ASTHMA, ASTHMA_EXCL

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ASTHMA_MIXED
CONTROL_EXCLUDE	J10_ASTHMA\|ASTHMA_EXCL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	%J458
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	%J458
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Asthma mixed form (mode) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Asthma mixed form (mode), excluding more controls

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2415	1434	981
Unadjusted period prevalence (%)	0.49	0.51	0.45
Median age at first event (years)	54.26	49.71	60.91

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2478: Matched controls
24774

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

21.7

323.3

246

125

J45.1

ICD-10 Finland

Nonallergic asthma

125.7

307.7

478

J45.9

ICD-10 Finland

Asthma, unspecified

71.3

307.7

1478

503

R03AC03

ATC

terbutaline; inhalant

10.9

307.7

741

933

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

22.9

307.7

310

154

H02AB06

ATC

prednisolone; systemic

10.7

307.7

1864

5457

R03BB04

ATC

tiotropium bromide; inhalant

56.2

307.7

705

174

R03AK08

ATC

formoterol and beclometasone; inhalant

43.9

307.7

312

XG474

NOMESCO Finland

Exhalation nntrogen oxide

89.3

307.7

271

R03BA05

ATC

fluticasone; inhalant

15.9

307.7

1139

1257

R03AC12

ATC

salmeterol; inhalant

92.5

307.7

423

R03AC02

ATC

salbutamol; inhalant

30.9

307.7

2285

6857

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

158.9

307.7

1974

596

R03DA04

ATC

theophylline; systemic, rectal

31.3

307.7

421

161

UGC12

NOMESCO Finland

Flexible bronchoscopy

28.0

307.7

321

131

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

101.5

307.7

247

J46

ICD-10 Finland

Status asthmaticus

160.0

307.7

219

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

6.2

307.7

688

1454

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

64.8

307.7

571

114

J45.8

ICD-10 Finland

Mixed asthma

+∞

307.7

2478

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

110.4

307.7

203

R03DC03

ATC

montelukast; oral

20.4

307.7

1117

956

R03AK07

ATC

formoterol and budesonide; inhalant

9.3

307.7

1032

1757

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

52.8

307.7

513

122

R03AK06

ATC

salmeterol and fluticasone; inhalant

28.6

307.7

1077

649

XG410

NOMESCO Finland

Flow-volume spirometry

32.1

307.7

212

R03BA02

ATC

budesonide; inhalant

14.8

307.7

1052

1176

R03BA08

ATC

ciclesonide; inhalant

12.0

307.7

433

430

J45.0

ICD-10 Finland

Predominantly allergic asthma

109.0

307.7

727

J18.9

ICD-10 Finland

Pneumonia, unspecified

17.6

307.7

797

651

R03AC13

ATC

formoterol; inhalant

32.1

307.7

340

122

R96

ICPC

Asthma

24.0

307.7

684

387

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

152.6

307.7

284

R03BA01

ATC

beclometasone; inhalant

16.2

307.7

910

857

J45

ICD-10 Finland

Asthma

20.6

307.7

630

404

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

45.0

307.7

280

R03AK03

ATC

[U] fenoterol and ipratropium bromide

16.3

287.1

251

170

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

42.4

281.8

170

R03BB01

ATC

ipratropium bromide; inhalant

18.8

267.2

216

125

R06.0

ICD-10 Finland

Dyspnoea

4.5

260.6

866

2627

XG405

NOMESCO Finland

Education on PEF monitoring

84.6

256.9

136

R06.2

ICD-10 Finland

Wheezing

13.0

232.9

232

196

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

8.6

232.0

316

412

R01AD08

ATC

fluticasone; nasal

4.0

226.6

898

3055

H02AB04

ATC

methylprednisolone; systemic

5.4

220.6

510

1140

J01MA14

ATC

moxifloxacin; systemic

8.4

218.5

305

409

R03DC01

ATC

zafirlukast; oral

48.9

207.8

121

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

7.0

206.4

344

561

J33.0

ICD-10 Finland

Polyp of nasal cavity

75.2

200.6

108

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

8.9

195.4

255

314

XQ800

NOMESCO Finland

Prick test

7.2

190.5

302

466

R01AD01

ATC

beclometasone; nasal

4.5

188.2

545

1454

R03AK11

ATC

formoterol and fluticasone; inhalant

22.1

182.5

136

J01FA06

ATC

roxithromycin; oral

3.3

180.3

1139

5093

R06AE07

ATC

cetirizine; oral

3.2

179.8

1316

6411

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

211.6

172.4

177

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

361.2

170.4

170

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

78.7

170.1

J34.2

ICD-10 Finland

Deviated nasal septum

40.9

168.0

102

SPAT1059

SPAT

Spirometry at the office

8.5

167.4

227

292

J01AA02

ATC

doxycycline; systemic

4.0

167.0

2028

13111

R95

ICPC

Chron obstructive pulmonary disease

23.5

164.2

119

R01AD09

ATC

mometasone; nasal

3.0

156.9

1226

6069

H02AB07

ATC

prednisone; oral

4.4

149.1

425

1108

R03BC03

ATC

nedocromil; inhalant

6.1

148.0

273

489

J31.0

ICD-10 Finland

Chronic rhinitis

7.6

147.7

220

315

Z01.8

ICD-10 Finland

Other specified special examinations

3.3

146.2

733

2798

TGC00

NOMESCO Finland

Bronchial lavation

41.4

145.5

EMB10

NOMESCO Finland

Tonsillectomy

29.9

143.1

R02

ICPC

Shortness of breath/dyspnoea

4.3

142.7

423

1134

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

141.0

134

J01.0

ICD-10 Finland

Acute maxillary sinusitis

3.3

135.4

666

2500

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

465.5

134.4

133

49300

ICD-8 Finland

Asthma, bronchiale

+∞

133.5

127

J35.0

ICD-10 Finland

Chronic tonsillitis

28.8

132.5

R03BC01

ATC

cromoglicic acid; inhalant

20.0

131.7

102

RD211, ,

NOMESCO Finland

6.4

130.2

226

380

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.7

125.2

1357

7693

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

14.1

125.1

116

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.7

119.8

303

714

R06AX27

ATC

desloratadine; oral

2.8

117.5

826

3745

J30.3

ICD-10 Finland

Other allergic rhinitis

10.5

116.7

131

J01FA10

ATC

azithromycin; systemic

2.6

116.6

1511

9227

R01AD58

ATC

fluticasone, combinations; nasal

2.9

112.7

670

2770

UDH02

NOMESCO Finland

Rhinopharyngoscopy

8.0

111.6

155

204

R01AD05

ATC

budesonide; nasal

5.3

111.0

240

495

R01AD12

ATC

fluticasone furoate; nasal

2.7

109.9

827

3861

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.5

109.8

1287

7425

J96.1

ICD-10 Finland

Chronic respiratory failure

+∞

109.2

104

WZC30

NOMESCO Finland

Teaching

3.2

108.2

511

1849

SPAT1058

SPAT

PEF monitoring instruction

4.8

107.8

265

609

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

23.3

106.2

J01FA09

ATC

clarithromycin; systemic

2.7

104.8

816

3859

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

45.4

104.7

S01GX01

ATC

cromoglicic acid; ophthalmic

2.9

104.6

613

2503

R01AD11

ATC

triamcinolone; nasal

4.5

104.3

273

659

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

5.6

102.1

202

384

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

182.6

101.1

105

J37.0

ICD-10 Finland

Chronic laryngitis

21.4

100.0

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

21.2

98.1

TDM10

NOMESCO Finland

Puncture of maxillary antrum

134.2

96.8

103

RF410, ,

NOMESCO Finland

12.8

95.2

R06AX13

ATC

loratadine; oral

3.2

94.9

437

1549

R06AX22

ATC

ebastine; oral

3.0

94.5

498

1907

J47

ICD-10 Finland

Bronchiectasis

464.2

90.8

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

12.6

89.3

R01AC01

ATC

cromoglicic acid; nasal

6.6

89.3

147

233

R04.2

ICD-10 Finland

Haemoptysis

9.2

87.8

108

122

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.3

87.7

377

1278

RF420, ,

NOMESCO Finland

11.6

87.5

C01CA24

ATC

epinephrine; parenteral

4.8

87.3

208

464

Z71.8

ICD-10 Finland

Other specified counselling

2.3

82.8

967

5388

J36

ICD-10 Finland

Peritonsillar abscess

45.4

82.7

UDM02

NOMESCO Finland

Sinoscopy

19.9

82.6

Z3231

NOMESCO Finland

Registered nurse

2.5

82.5

717

3510

R06AE09

ATC

levocetirizine; oral

3.0

82.2

413

1531

C03CA01

ATC

furosemide; systemic

2.4

81.7

735

3653

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

28.1

81.2

GD1AA, ,

SPAT

2.9

80.8

464

1851

R5140

NOMESCO Finland

Monitoring the use of the aid

3.4

78.9

309

986

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

792.7

78.8

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

14.2

78.6

R05

ICD-10 Finland

Cough

2.6

78.2

550

2429

N02AX02

ATC

tramadol; systemic, rectal

2.2

75.7

1015

5933

XG466

NOMESCO Finland

Sleep oxymetry

9.1

75.0

106

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

104.6

74.3

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

74.3

Z00.0

ICD-10 Finland

General medical examination

2.5

73.2

579

2696

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.4

73.1

673

3356

A01AB09

ATC

miconazole; local oral

3.6

71.6

256

768

SPAT1252

SPAT

Overall medication plan or its review

3.8

71.2

231

649

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

707.7

70.4

A02BC03

ATC

lansoprazole; oral

2.3

68.6

685

3524

A02BC05

ATC

esomeprazole; systemic

2.1

68.0

942

5522

GD1AD

NOMESCO Finland

Thorax CT examination

5.3

67.6

141

280

R06AX26

ATC

fexofenadine; oral

3.8

66.9

216

604

R01BA52

ATC

pseudoephedrine, combinations; oral

2.3

66.7

685

3560

SPAT1057

SPAT

Peak expiratory flow measurement

8.8

65.6

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.2

65.3

728

3906

A02BC02

ATC

pantoprazole; systemic

2.1

64.2

1578

11337

R05

ICPC

Cough

2.3

64.1

620

3135

J01FA15

ATC

telithromycin; oral

3.5

63.5

241

750

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

8.0

61.4

108

G47.3

ICD-10 Finland

Sleep apnoea

2.4

60.9

502

2362

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

60.7

1003

6213

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

59.9

906

5431

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

14.5

59.7

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.2

59.6

254

849

J35.2

ICD-10 Finland

Hypertrophy of adenoids

591.7

58.9

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

9.4

58.5

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

58.4

951

5842

J01MA12

ATC

levofloxacin; systemic

2.6

58.1

393

1684

J01DA01

ATC

[U] cefalexin

2.0

57.7

1445

10278

N03AX12

ATC

[U] gabapentin; oral

2.6

57.6

383

1627

DJD20

NOMESCO Finland

Plastic repair of septum of nose

82.2

57.2

M54.5

ICD-10 Finland

Low back pain

2.0

56.5

882

5323

I50.9

ICD-10 Finland

Heart failure, unspecified

2.7

56.2

328

1304

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

10.8

56.0

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

55.6

665

3634

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

4.9

55.2

125

266

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

54.8

782

4561

XG460

NOMESCO Finland

Short time oxymetry

11.0

54.0

C07AB07

ATC

bisoprolol; oral

1.9

53.8

1089

7154

A02BC01

ATC

omeprazole; systemic

2.1

53.7

640

3486

EMB30

NOMESCO Finland

Adenotomy

9.6

53.4

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

52.3

DHB20

NOMESCO Finland

Polypectomy of internal nose

183.9

52.1

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

97.2

52.0

R05FB02

ATC

cough suppressants and expectorants; systemic

2.0

51.8

847

5163

R50.9

ICD-10 Finland

Fever, unspecified

2.6

51.3

350

1500

R81

ICPC

Pneumonia

6.1

51.3

155

J33.8

ICD-10 Finland

Other polyp of sinus

95.5

51.0

R03CC02

ATC

salbutamol; systemic

3.2

50.6

209

684

ZYC01

NOMESCO Finland

Remote contact by phone

3.4

50.5

193

602

A07AA02

ATC

nystatin; oral

3.9

50.0

153

411

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.1

49.9

581

3125

J01FF01

ATC

clindamycin; systemic

2.1

48.9

592

3229

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.3

48.9

462

2286

J01CA04

ATC

amoxicillin; systemic

2.1

48.9

1955

15863

R51.80

ICD-10 Finland

Headache

2.4

48.7

391

1804

I50.0

ICD-10 Finland

Congestive heart failure

3.4

48.6

184

570

N03AX16

ATC

[U] pregabalin

2.2

47.9

492

2517

SPAT1359

SPAT

Use of symptom diary

5.3

47.4

189

J20

ICD-10 Finland

Acute bronchitis

2.9

46.6

240

890

L20.0

ICD-10 Finland

Besnier prurigo

2.9

46.6

231

839

RF120, ,

NOMESCO Finland

8.4

45.9

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

45.2

523

2796

SPAT1257

SPAT

Teaching of medicine inhalation technique

5.3

44.8

176

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

44.5

325

1434

R06.5

ICD-10 Finland

Mouth breathing

3.0

44.2

207

728

J02AC01

ATC

fluconazole; systemic

1.9

44.1

897

5805

E0000UV, ,

ATC

1.8

44.0

999

6687

R05FA02

ATC

opium derivatives and expectorants; systemic

1.8

43.7

912

5944

R05CA10

ATC

expectorants - combinations

6.0

43.4

131

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

5.6

42.9

150

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

42.9

430

2170

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

+∞

42.8

T78.4

ICD-10 Finland

Allergy, unspecified

3.9

42.5

129

344

Z51.6

ICD-10 Finland

Desensitization to allergens

62.4

42.3

R03BB02

ATC

oxitropium bromide; inhalant

62.4

42.3

J01DB01

ATC

cefalexin; oral

2.0

42.3

1900

15545

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

42.1

249

992

E66.01

ICD-10 Finland

Obesity due to excess calories

2.7

41.6

237

926

RF210, ,

NOMESCO Finland

4.6

41.5

100

224

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.3

41.4

109

262

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

41.3

946

6318

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

414.2

41.2

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.7

41.1

134

376

N06AX21

ATC

duloxetine; oral

2.5

41.0

277

1176

J32.4

ICD-10 Finland

Chronic pansinusitis

145.8

40.9

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

40.7

GX1E5, ,

SPAT

9.6

40.7

SPAT1325

SPAT

Vaccination

1.8

40.4

817

5246

A02BA02

ATC

ranitidine; systemic

2.1

39.8

424

2186

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

15.7

39.2

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

38.6

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

52.0

38.6

Z25.1

ICD-10 Finland

Need for immunization against influenza

3.1

38.3

170

579

N02BE01

ATC

paracetamol; systemic, rectal

2.1

38.2

2085

17817

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

38.1

658

4009

A01AB04

ATC

amphotericin B; local oral

3.8

38.1

119

324

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.9

38.0

179

R1250

NOMESCO Finland

Evaluation of functional capability

4.8

38.0

183

D86.0

ICD-10 Finland

Sarcoidosis of lung

+∞

37.6

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

101.6

36.8

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.3

36.5

321

1530

R53

ICD-10 Finland

Malaise and fatigue

1.9

36.2

590

3522

ZX120

NOMESCO Finland

Intravenous

2.6

36.0

219

883

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

35.5

J01MA02

ATC

ciprofloxacin; systemic

1.7

34.8

832

5560

Z3229

NOMESCO Finland

Other healthcare associate professional

2.6

34.8

211

849

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

125.1

34.8

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

34.7

599

3634

J01DA06

ATC

[U] cefuroxime

2.2

34.6

309

1481

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

4.3

34.4

215

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

9.7

34.2

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

341.7

34.0

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

8.4

33.9

R03BB07

ATC

umeclidinium bromide; inhalant

46.2

33.8

SPAT1131

SPAT

Colonoscopy

3.9

33.7

101

267

R60.0

ICD-10 Finland

Localized oedema

2.3

33.5

290

1371

J96.0

ICD-10 Finland

Acute respiratory failure

+∞

33.4

HMAK, ,

NOMESCO Finland

2.2

33.4

308

1494

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

33.4

413

2240

M79.6

ICD-10 Finland

Pain in limb

1.7

32.8

965

6798

SPAT1254

SPAT

Administration of medicine

2.1

32.6

350

1800

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.1

32.5

229

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

32.4

R28

ICPC

Limited function/disability (R)

9.2

32.1

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

73.2

31.9

H02AB09

ATC

hydrocortisone; systemic

5.2

31.7

127

DHB50

NOMESCO Finland

Turbinoplasty

48.2

31.6

N06AX16

ATC

venlafaxine; oral

2.1

31.5

315

1577

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

31.5

708

4627

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

39.6

31.2

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

8.8

31.0

R05CB01

ATC

acetylcysteine; inhalant, oral

7.6

31.0

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

30.9

176

685

G43.9

ICD-10 Finland

Migraine, unspecified

2.9

30.9

155

565

R74

ICPC

Upper respiratory infection acute

1.7

30.8

734

4867

R29

ICPC

Respiratory symptom/complaint other

2.8

30.8

156

571

R03AC18

ATC

indacaterol; inhalant

162.0

30.7

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

30.1

212

915

M79.7

ICD-10 Finland

Fibromyalgia

4.0

30.0

220

J35.1

ICD-10 Finland

Hypertrophy of tonsils

68.8

29.9

R01AC07

ATC

nedocromil; nasal

12.1

29.9

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

3.9

29.8

230

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.4

29.8

226

1008

N05CF01

ATC

zopiclone; oral

1.7

29.8

673

4392

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

29.7

237

1080

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

108.0

29.7

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

7.2

29.7

J04.0

ICD-10 Finland

Acute laryngitis

4.1

29.5

201

J01DA09

ATC

[U] cefadroxil

1.8

29.4

569

3552

SPAT1263

SPAT

Sampling

1.6

29.3

920

6544

N06AX11

ATC

mirtazapine; oral

1.7

28.5

722

4849

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

28.4

410

2333

N06AA09

ATC

amitriptyline; systemic

2.4

28.1

203

885

J01FA01

ATC

erythromycin; systemic

2.0

28.0

318

1666

R49.08

ICD-10 Finland

Other specified dysphonia

5.4

27.8

104

J43.9

ICD-10 Finland

Emphysema, unspecified

43.0

27.7

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

9.1

27.7

S01GX02

ATC

levocabastine; ophthalmic

2.8

27.7

146

546

N05BA04

ATC

oxazepam; oral

1.7

27.7

582

3711

R42

ICD-10 Finland

Dizziness and giddiness

1.8

27.6

516

3182

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

4.8

27.4

132

P01AB01

ATC

metronidazole; oral, rectal

1.6

27.3

841

5927

WZC30, ,

SPAT

2.3

27.3

221

1013

E000002, ,

ATC

2.1

27.0

264

1307

J33.9

ICD-10 Finland

Nasal polyp, unspecified

10.9

26.9

M03BX02

ATC

tizanidine; oral

1.6

26.9

1300

10185

WQ000

NOMESCO Finland

Hyposensibilisation

97.8

26.7

M48.0

ICD-10 Finland

Spinal stenosis

2.1

26.5

259

1281

Z00.8

ICD-10 Finland

Other general examinations

2.3

26.4

209

948

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

26.4

157

625

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.0

26.2

120

416

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

+∞

26.1

E000001, ,

ATC

1.8

26.1

440

2626

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

26.0

686

4639

J01DA08

ATC

[U] cefaclor

2.1

25.9

273

1389

C08DA01

ATC

verapamil; systemic

3.2

25.7

105

340

SPAT1310

SPAT

Counselling related to known health issue

1.6

25.4

708

4851

R07.3

ICD-10 Finland

Other chest pain

2.2

25.3

226

1079

N06AB04

ATC

citalopram; systemic

1.8

25.1

413

2444

A44

ICPC

General and Unspecified, Preventive immunization/medic

2.2

25.1

231

1116

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

+∞

25.0

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

+∞

25.0

L28

ICPC

Limited function/disability (L)

1.8

25.0

402

2361

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

6.3

24.9

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

24.8

198

901

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.6

24.8

734

5098

XG405, ,

SPAT

8.1

24.8

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

252.6

24.7

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

5.1

24.7

104

R01AD59

ATC

mometasone, combinations; nasal

2.6

24.7

152

615

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.9

24.6

192

I45.9

ICD-10 Finland

Conduction disorder, unspecified

8.3

24.4

D07AC13

ATC

mometasone; topical

1.7

24.4

610

4058

A46

ICD-10 Finland

Erysipelas

2.0

24.3

290

1544

M05BA04

ATC

alendronic acid; oral

2.3

24.2

186

833

-1, ,

NOMESCO Finland

1.6

23.9

761

5368

E66.8

ICD-10 Finland

Other obesity

2.8

23.9

126

471

E66.9

ICD-10 Finland

Obesity, unspecified

3.3

23.8

278

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

126.2

23.6

D07AC01

ATC

betamethasone; topical

1.6

23.5

769

5456

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.9

23.5

332

1870

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

3.7

23.4

208

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

23.0

190

878

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

22.9

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

3.9

22.9

179

EMB20

NOMESCO Finland

Adenotonsillectomy

84.2

22.7

L03

ICPC

Low back symptom/complaint

1.6

22.7

629

4283

C03DA01

ATC

spironolactone; oral

2.0

22.7

249

1285

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

22.7

206

989

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

3.2

22.6

287

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

22.6

173

773

S18

ICPC

Laceration/cut

1.5

22.6

994

7526

N05BA01

ATC

diazepam; systemic, rectal

2.0

22.5

264

1395

N05BB01

ATC

hydroxyzine; systemic

2.5

22.5

149

624

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

22.5

255

1331

SPAT1360

SPAT

Extensive global examination

2.4

22.5

162

705

N02AA05

ATC

oxycodone; systemic

1.8

22.4

359

2103

R52.2

ICD-10 Finland

Other chronic pain

3.2

22.1

281

H66.9

ICD-10 Finland

Otitis media, unspecified

2.4

22.1

156

673

D07AA02

ATC

hydrocortisone; topical

1.9

22.0

312

1756

ZXA10

NOMESCO Finland

Bilateral

1.8

22.0

354

2074

S15

ICPC

Foreign body in skin

2.3

21.9

165

732

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

+∞

21.9

132

Kela drug reimbursment

Sarcoidosis

+∞

21.9

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.9

21.8

107

385

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.8

21.8

111

408

J42

ICD-10 Finland

Unspecified chronic bronchitis

18.6

21.7

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

6.0

21.7

R06AX11

ATC

astemizole; oral

3.3

21.6

249

M25.5

ICD-10 Finland

Pain in joint

1.6

21.5

677

4741

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

21.5

717

5089

Z51.0

ICD-10 Finland

Radiotherapy session

4.6

21.5

113

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

21.4

631

4352

GX2C5

NOMESCO Finland

Short-lasting oximetry

26.6

21.3

GX1K5

NOMESCO Finland

Diffusion capacity

26.6

21.3

R83

ICPC

Respiratory infection other

1.6

21.2

570

3842

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.3

21.2

172

788

Z50.5

ICD-10 Finland

Speech therapy

5.6

21.0

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

28.3

20.9

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

20.9

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

+∞

20.9

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.3

20.8

245

J30.0

ICD-10 Finland

Vasomotor rhinitis

4.8

20.8

100

Z72.0

ICD-10 Finland

Tobacco use

4.7

20.8

104

49099

ICD-8 Finland

Bronchitis, unspecified

7.4

20.8

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

37.5

20.8

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.9

20.6

160

J01DC02

ATC

cefuroxime; systemic

2.7

20.5

110

415

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.3

20.5

242

R4110, ,

SPAT

1.9

20.5

303

1727

XA402

NOMESCO Finland

ENMG

3.8

20.3

162

A41.9

ICD-10 Finland

Sepsis, unspecified

3.4

20.3

219

M01AE02

ATC

naproxen; oral, rectal

1.5

20.2

1226

9846

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

20.1

372

2267

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

20.0

264

1451

SPAT1216

SPAT

Assessment of functional ability

1.8

20.0

328

1931

N05AH04

ATC

quetiapine; oral

1.8

20.0

357

2155

J01.1

ICD-10 Finland

Acute frontal sinusitis

7.3

19.9

N06AB03

ATC

fluoxetine; oral

1.9

19.9

255

1387

A03FA02

ATC

cisapride; oral, rectal

2.2

19.9

165

763

SPAT1240

SPAT

Therapeutic discussion

2.0

19.8

235

1246

UJF32

NOMESCO Finland

Coloscopy

1.6

19.7

503

3341

R49.01

ICD-10 Finland

Functional dysphonia

3.6

19.6

180

RP210, ,

NOMESCO Finland

105.9

19.6

M04AA01

ATC

allopurinol; systemic

1.9

19.6

247

1337

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

19.4

274

1538

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

6.2

19.4

N03AX09

ATC

lamotrigine; oral

2.8

19.2

366

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

19.1

500

3337

I50.1

ICD-10 Finland

Left ventricular failure

2.7

19.0

100

374

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

4.9

19.0

A03

ICPC

Fever

1.7

19.0

353

2154

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.1

18.9

125

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

55.4

18.9

OAB71, ,

SPAT

6.2

18.9

N05CD07

ATC

temazepam; oral

2.0

18.9

232

1243

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.0

18.9

228

1215

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.8

18.9

283

1619

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

18.9

278

1582

DPA30

NOMESCO Finland

Sphenotomy

+∞

18.8

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

+∞

18.8

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

18.8

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

18.8

S01GX08

ATC

ketotifen; ophthalmic

2.6

18.8

108

423

V01AA05

ATC

tree pollen; parenteral

7.7

18.7

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

18.6

425

2740

H65.3

ICD-10 Finland

Chronic mucoid otitis media

4.1

18.5

127

G44.2

ICD-10 Finland

Tension-type headache

1.9

18.5

273

1553

SPAT1301

SPAT

No procedures

1.5

18.5

662

4747

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

4.8

18.5

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

18.5

631

4479

GX1C5, ,

SPAT

13.6

18.2

PLAK0, ,

NOMESCO Finland

5.6

18.2

SPAT1260

SPAT

Consultation of another employee

1.7

18.2

353

2178

A06AD11

ATC

lactulose; oral

1.8

18.1

295

1730

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

18.1

251

1400

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

18.0

211

1113

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

18.0

614

4354

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

33.1

18.0

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

+∞

17.7

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

17.7

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

+∞

17.7

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

17.6

1235

10093

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

17.6

404

2605

Angiography of the heart and coronary arteries

2.3

17.6

129

566

I20.00

ICD-10 Finland

Unstable angina

3.3

17.5

209

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

17.3

204

1078

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

17.1

399

2582

SPAT1255

SPAT

Intravenous administration of medicine

2.3

17.0

127

562

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

17.0

960

7523

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

17.5

16.9

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.6

16.7

101

405

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

+∞

16.7

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

+∞

16.7

348

Kela drug reimbursment

Roflumilast

+∞

16.7

J35.3

ICD-10 Finland

Hypertrophy of tonsils with hypertrophy of adenoids

+∞

16.7

AN1

Coronary angiography

1.9

16.6

203

1085

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.4

16.6

120

523

R21

ICPC

Throat symptom/complaint

1.6

16.6

453

3046

M01AH02

ATC

rofecoxib; oral

1.9

16.5

239

1351

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

16.4

826

6318

D07BC01

ATC

betamethasone and antiseptics; topical

1.9

16.3

236

1333

WX308

NOMESCO Finland

Sacral anesthesy

14.3

16.3

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.7

16.3

317

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

30.2

16.1

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

16.1

312

1921

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

5.3

16.1

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.7

16.0

343

R1250, ,

SPAT

2.7

15.9

338

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

15.9

176

909

E66.00

ICD-10 Finland

Metabolic syndrome

2.4

15.9

106

446

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

15.8

482

3319

N02BF01

ATC

gabapentin; oral

1.9

15.8

197

1060

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.4

15.8

107

453

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

60.4

15.8

WW200

NOMESCO Finland

Immunization

3.4

15.8

167

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

15.8

15.7

RF421, ,

NOMESCO Finland

6.9

15.7

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

15.7

343

2180

WZC00, ,

SPAT

1.7

15.7

335

2117

RF220, ,

NOMESCO Finland

4.7

15.6

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

15.6

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

15.6

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

15.6

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

15.6

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.4

15.6

103

431

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

6.1

15.6

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

15.6

853

6616

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

15.5

221

1243

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

160.9

15.5

X58

ICD-10 Finland

Exposure to other specified factors

1.7

15.5

295

1808

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

15.4

424

2850

E000003, ,

ATC

2.5

15.4

385

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

15.4

157

788

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

15.3

472

3257

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

5.5

15.2

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.9

15.2

255

R06AX12

ATC

terfenadine; oral

2.5

15.2

394

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

15.1

275

1663

R2110

NOMESCO Finland

Giving the first information

2.1

15.1

137

657

D11AH01

ATC

tacrolimus; topical

5.7

15.1

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.5

15.0

378

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

15.0

866

6771

R52.9

ICD-10 Finland

Pain, unspecified

1.9

14.9

205

1139

M79.1

ICD-10 Finland

Myalgia

1.7

14.9

299

1856

ZXC60

NOMESCO Finland

Application of heat

6.8

14.9

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

14.8

322

2041

B01AA03

ATC

warfarin; systemic

1.6

14.8

352

2283

R03AC19

ATC

olodaterol

31.9

14.8

M01AH05

ATC

etoricoxib; oral

1.4

14.8

1257

10502

N06AB10

ATC

escitalopram; oral

1.6

14.7

415

2805

N18.8

ICD-10 Finland

Other chronic renal failure

3.5

14.7

145

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

14.6

J94.8

ICD-10 Finland

Other specified pleural conditions

80.6

14.6

S06.0

ICD-10 Finland

Concussion

1.8

14.6

217

1237

A02BA04

ATC

nizatidine; systemic

2.1

14.5

144

715

UDC00

NOMESCO Finland

Ear microscopy

2.1

14.5

133

641

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

150.8

14.5

J38.2

ICD-10 Finland

Nodules of vocal cords

150.8

14.5

R03BA07

ATC

mometasone; inhalant

6.6

14.5

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

14.4

142

703

J30.19

ICD-10 Finland

Pollen allergy UNS

2.5

14.4

386

P76

ICPC

Depressive disorder

2.1

14.4

143

711

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.0

14.3

214

KHV, ,

NOMESCO Finland

5.6

14.3

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

27.3

14.3

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.0

14.3

204

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

3.1

14.2

199

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

14.1

230

1347

J15.8

ICD-10 Finland

Other bacterial pneumonia

42.7

14.1

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

14.1

115

529

N07BA03

ATC

varenicline; oral

2.6

14.1

318

R07

ICPC

Sneezing/nasal congestion

2.1

14.1

135

662

C01AA05

ATC

digoxin; systemic

2.0

14.1

163

856

Z08

ICPC

Social welfare problem

4.4

14.0

B01AC04

ATC

clopidogrel; oral

1.7

14.0

291

1823

R5110, ,

SPAT

1.9

14.0

176

950

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

14.0

250

1504

SPAT1097

SPAT

Recording of ECG

1.7

13.9

272

1677

G43.3

ICD-10 Finland

Complicated migraine

3.8

13.9

108

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

5.6

13.8

WW200, ,

SPAT

1.5

13.8

624

4648

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

13.8

143

722

N03AE01

ATC

clonazepam; systemic

2.3

13.8

104

463

XA420

NOMESCO Finland

Extensive sleep examination

6.3

13.7

A02BX02

ATC

sucralfate; oral

2.5

13.7

334

4224

FHL

Endonasal anthrostomy

6.5

13.6

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

13.6

291

1836

M05BA07

ATC

risedronic acid; oral

2.8

13.6

237

M54.6

ICD-10 Finland

Pain in thoracic spine

2.0

13.6

151

781

GDC00

NOMESCO Finland

Lobectomy of lung

75.5

13.6

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

75.5

13.6

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.5

13.6

366

1350A

ICD-9 Finland

Sarcoidosis[SARCOIDOSIS]

+∞

13.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

13.5

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

13.5

R03DX07

ATC

roflumilast; oral

+∞

13.5

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

13.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

13.5

303

1935

R03AC04

ATC

fenoterol; inhalant

34.2

13.5

J32.1

ICD-10 Finland

Chronic frontal sinusitis

140.7

13.5

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.3

13.4

102

455

N06AA12

ATC

doxepin; systemic

2.3

13.4

424

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

13.4

379

2561

Y0499

ICD-8 Finland

Investigation of respiratory system

5.0

13.4

SPAT1153

SPAT

Removal of sutures

1.5

13.3

601

4471

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.9

13.3

102

N02BF02

ATC

pregabalin; oral

2.1

13.3

119

568

E000007, ,

ATC

2.2

13.3

114

535

H57.1

ICD-10 Finland

Ocular pain

2.4

13.2

370

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

13.2

422

2927

S22.3

ICD-10 Finland

Fracture of rib

2.0

13.1

138

700

XG422, ,

SPAT

15.1

13.1

TQW80

NOMESCO Finland

Local dermatologic skincare

2.9

13.1

220

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

13.1

195

1112

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

5.5

13.1

M10.9

ICD-10 Finland

Gout, unspecified

2.1

13.0

121

586

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

13.0

416

2885

I45.8

ICD-10 Finland

Other specified conduction disorders

11.0

13.0

R11

ICD-10 Finland

Nausea and vomiting

1.9

12.9

175

968

C07AB05

ATC

betaxolol; oral

2.9

12.9

211

E000006, ,

ATC

2.0

12.9

132

664

H92.0

ICD-10 Finland

Otalgia

2.0

12.8

134

678

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.5

12.8

339

R09

ICPC

Sinus symptom/complaint

2.0

12.8

150

791

M02AA07

ATC

piroxicam; topical

1.4

12.7

668

5107

R01AX03

ATC

ipratropium bromide; nasal

3.5

12.6

125

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

70.2

12.6

J92.9

ICD-10 Finland

Pleural plaque without asbestos

70.2

12.6

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.2

12.6

111

527

B37.08

ICD-10 Finland

Other candidal stomatitis

5.5

12.6

GX1D5

NOMESCO Finland

Flow volume spirometry

32.2

12.6

V01AA02

ATC

grass pollen; parenteral

32.2

12.6

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

12.6

214

J98.6

ICD-10 Finland

Disorders of diaphragm

+∞

12.5

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

+∞

12.5

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

5.2

12.5

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

12.5

108

509

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

9.3

12.5

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

12.5

230

1395

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

130.6

12.4

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

130.6

12.4

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

12.4

808

6400

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.0

12.4

143

750

S80.0

ICD-10 Finland

Contusion of knee

1.9

12.3

153

823

L50.0

ICD-10 Finland

Allergic urticaria

2.8

12.2

217

ZX100

NOMESCO Finland

Oral

4.2

12.2

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

10.5

12.2

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.5

12.2

118

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

12.2

377

2592

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

12.2

109

520

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

12.2

176

993

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

12.2

173

971

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

12.2

141

740

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

12.2

366

L27.2

ICD-10 Finland

Dermatitis due to ingested food

4.9

12.2

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

12.1

496

3615

XQ848

NOMESCO Finland

Dermatological photography

2.6

12.1

276

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

12.0

536

3968

L01

ICPC

Neck symptom/complaint

1.6

12.0

326

2178

R03

ICPC

Wheezing

5.3

12.0

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

10.1

12.0

R03DA05

ATC

aminophylline; systemic, rectal

9.3

12.0

A02BC04

ATC

rabeprazole; oral

1.9

12.0

157

860

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.1

12.0

155

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.8

11.9

220

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

11.9

272

D07AB08

ATC

desonide; topical

1.7

11.9

210

1258

K59.0

ICD-10 Finland

Constipation

2.1

11.9

112

546

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

46.9

11.9

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.7

11.8

252

1587

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

11.8

228

1399

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

3.9

11.8

4222

FHL

Endonasal etmoidectomy

11.8

J01EA01

ATC

trimethoprim; systemic

1.4

11.7

528

3915

C10AA01

ATC

simvastatin; oral

1.4

11.7

772

6115

SPAT1098

SPAT

Exercise ECG

3.1

11.7

152

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

11.7

735

5779

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.4

11.7

348

WZA10

NOMESCO Finland

Extensive medical or dental certificate

4.0

11.7

R06

ICD-10 Finland

Abnormalities of breathing

4.6

11.6

P29

ICPC

Psychological sympt/compl other

1.8

11.6

167

941

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

11.6

225

1382

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.9

11.6

148

803

J98.1

ICD-10 Finland

Pulmonary collapse

65.2

11.6

XG430

NOMESCO Finland

Spiroegometry

23.0

11.6

C08CA13

ATC

lercanidipine; oral

1.6

11.5

282

1838

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

3.2

11.5

143

R39

ICPC

Respiratory, Physical function test

8.6

11.5

D02AE01

ATC

carbamide; topical

2.0

11.5

122

622

R04

ICPC

Breathing problem other

2.4

11.5

332

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

11.5

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

+∞

11.5

J05AB01

ATC

aciclovir; systemic

1.5

11.4

422

3011

G04CA02

ATC

tamsulosin; oral

1.5

11.4

411

2918

N03AG01

ATC

valproic acid; systemic, rectal

2.1

11.4

101

481

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

11.4

108

528

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

11.4

204

1227

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

11.4

473

3454

M01AC06

ATC

meloxicam; systemic, rectal

1.4

11.3

675

5255

D07AD01

ATC

clobetasol; topical

1.6

11.3

321

2166

RJ190, ,

NOMESCO Finland

35.2

11.3

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

4.5

11.2

C08DB01

ATC

diltiazem; oral

2.1

11.2

106

518

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.8

11.2

194

N06AX12

ATC

bupropion; oral

1.9

11.2

136

727

M54.1

ICD-10 Finland

Radiculopathy

2.4

11.2

330

J38.3

ICD-10 Finland

Other diseases of vocal cords

25.1

11.1

J01.4

ICD-10 Finland

Acute pansinusitis

25.1

11.1

D11AH05

ATC

dupilumab; topical

25.1

11.1

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

12.8

11.1

M54.3

ICD-10 Finland

Sciatica

2.0

11.1

113

567

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

11.1

228

1424

A12BA01

ATC

potassium chloride; oral

2.3

11.0

363

S16

ICPC

Bruise/contusion

2.5

11.0

277

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

11.0

183

1078

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

11.0

230

RD210, ,

NOMESCO Finland

3.4

11.0

112

PLAK1, ,

NOMESCO Finland

3.7

11.0

N02AA01

ATC

morphine; systemic, rectal

3.4

11.0

117

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.6

10.9

248

P01

ICPC

Feeling anxious/nervous/tense

1.6

10.8

281

1856

C09CA06

ATC

candesartan; oral

1.5

10.8

448

3265

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.2

10.8

405

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

10.8

302

2029

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

4.2

10.8

R06AX18

ATC

acrivastine; oral

2.8

10.8

187

P03

ICPC

Feeling depressed

1.7

10.8

209

1285

H01

ICPC

Ear pain/earache

1.6

10.7

231

1458

J11.8

ICD-10 Finland

Influenza with other manifestations, virus not identified

9.6

10.7

E66.0

ICD-10 Finland

Obesity due to excess calories

4.4

10.7

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.7

10.7

R05CB02

ATC

bromhexine; systemic

3.7

10.7

N02AC04

ATC

dextropropoxyphene; oral

2.4

10.6

306

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

10.6

306

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

60.2

10.6

R5120

NOMESCO Finland

Preparation of an aid

2.5

10.6

258

WX722

NOMESCO Finland

PEEP

2.5

10.6

264

M01AH01

ATC

celecoxib; oral

1.5

10.6

316

2154

EB1VA, ,

NOMESCO Finland

1.5

10.6

349

2430

M54.2

ICD-10 Finland

Cervicalgia

1.8

10.6

153

865

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

10.6

100

489

J32

ICD-10 Finland

Chronic sinusitis

11.3

10.5

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.7

10.5

N06AX26

ATC

vortioxetine; oral

1.8

10.5

154

874

S01ED02

ATC

betaxolol; ophthalmic

4.6

10.5

A01

ICPC

Pain general/multiple sites

1.7

10.5

181

1078

N04BC05

ATC

pramipexole; oral

1.9

10.4

136

744

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.0

10.4

152

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

110.5

10.4

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

110.5

10.4

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

110.5

10.4

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

+∞

10.4

J43.8

ICD-10 Finland

Other emphysema

+∞

10.4

L04AX01

ATC

azathioprine; systemic

2.4

10.4

303

S01GX06

ATC

emedastine; ophthalmic

4.1

10.4

K05

ICPC

Irregular heartbeat other

2.3

10.4

328

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

10.4

105

526

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.0

10.4

107

540

ZX108, ,

SPAT

16.1

10.3

RF310, ,

NOMESCO Finland

16.1

10.3

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

32.6

10.3

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

10.3

1534

13627

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

10.3

388

2776

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

10.3

220

1387

RF430, ,

NOMESCO Finland

8.8

10.3

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

4.4

10.3

ZX140

NOMESCO Finland

Intra articular

4.9

10.3

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.5

10.2

269

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.5

10.2

251

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

10.2

231

1478

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

10.2

429

B02AA02

ATC

tranexamic acid; systemic

1.6

10.2

279

1867

I20.09

ICD-10 Finland

Unstable angina

2.1

10.1

483

C07AA05

ATC

propranolol; systemic

1.5

10.1

379

2707

K30

ICD-10 Finland

Functional dyspepsia

1.6

10.1

214

1346

R13

ICD-10 Finland

Dysphagia

1.9

10.1

117

616

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

8.5

10.0

H65.2

ICD-10 Finland

Chronic serous otitis media

4.0

10.0

48509

ICD-8 Finland

Bronchopneumonia, unspecified

4.5

10.0

ND2AA, ,

SPAT

2.0

10.0

105

534

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

10.0

124

668

ZX114

NOMESCO Finland

Intramuscular

3.7

10.0

J96.9

ICD-10 Finland

Respiratory failure, unspecified

40.2

10.0

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

10.0

165

971

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

10.0

121

647

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.9

9.9

118

626

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.8

9.9

173

C08CA01

ATC

amlodipine; oral

1.4

9.9

699

5569

N05BA12

ATC

alprazolam; oral

1.7

9.9

178

1072

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.5

9.9

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

9.9

171

1019

R39.1

ICD-10 Finland

Other difficulties with micturition

2.5

9.9

261

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

3.7

9.9

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

9.9

317

UJC12

NOMESCO Finland

Flexible oesophagoscopy

8.1

9.8

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

9.8

143

811

D02AX

ATC

Other emollients and protectives

2.5

9.8

238

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.2

9.8

376

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

9.8

344

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.2

9.8

344

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.1

9.7

470

S76

ICPC

Skin infection other

2.0

9.7

100

505

J38.4

ICD-10 Finland

Oedema of larynx

55.2

9.6

4226

FHL

Posterior radical surgery and possible etmoidectomy

7.8

9.6

N06AX03

ATC

mianserin; oral

2.1

9.6

399

R78

ICPC

Acute bronchitis/bronchiolitis

3.2

9.6

112

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.4

9.6

265

L50.9

ICD-10 Finland

Urticaria, unspecified

2.2

9.5

341

EBA00

NOMESCO Finland

Extraction of tooth

1.3

9.5

753

6096

N05CF02

ATC

zolpidem; oral

1.5

9.5

306

2118

R01AC02

ATC

levocabastine; nasal

2.7

9.5

183

J01

ICD-10 Finland

Acute sinusitis

2.1

9.5

448

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

9.5

163

970

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

3.2

9.5

118

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.4

9.4

279

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.0

9.4

103

531

JN3AE, ,

SPAT

2.1

9.4

395

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

9.4

132

739

ZY010

NOMESCO Finland

Hospital outpatient

2.0

9.4

476

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

100.4

9.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

100.4

9.4

UDQ02

NOMESCO Finland

Direct laryngoscopy

7.6

9.4

Z01.2

ICD-10 Finland

Dental examination

1.3

9.4

978

8228

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.4

9.4

249

J93.9

ICD-10 Finland

Pneumothorax, unspecified

+∞

9.4

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

9.4

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

9.4

J93.8

ICD-10 Finland

Other pneumothorax

+∞

9.4

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

+∞

9.4

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

9.4

363

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.8

9.3

162

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

2.3

9.3

293

C09CA01

ATC

losartan; oral

1.4

9.3

471

3552

H10.4

ICD-10 Finland

Chronic conjunctivitis

4.7

9.3

K07

ICPC

Swollen ankles/oedema

2.1

9.3

431

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.0

9.2

136

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

9.2

348

2490

UJD02

NOMESCO Finland

Gastroscopy

2.1

9.2

413

48609

ICD-8 Finland

Pneumonia, unspecified

3.7

9.2

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

9.1

246

1638

J05AH02

ATC

oseltamivir; oral

7.7

9.1

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.2

9.1

335

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

3.0

9.1

137

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

9.1

428

3187

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

4.6

9.1

WYA00, ,

SPAT

3.2

9.0

106

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

9.0

402

4239

FHL

Other measure in this category

15.6

9.0

R05DB05

ATC

pentoxyverine; oral, rectal

2.3

9.0

285

SPAT1229

SPAT

Assessment of need for aid

1.8

9.0

128

721

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

9.0

184

1148

A92

ICPC

Allergy/allergic reaction NOS

2.4

9.0

267

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

18.7

8.9

RF313, ,

NOMESCO Finland

18.7

8.9

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

8.9

197

1252

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

8.9

493

R03DB04

ATC

theophylline and adrenergics; systemic

24.1

8.9

395

Kela drug reimbursment

Dupilumab

24.1

8.9

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

8.9

137

790

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.2

8.9

345

A02BA03

ATC

famotidine; systemic

2.3

8.9

281

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

8.0

8.8

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.4

8.8

238

N39.3

ICD-10 Finland

Stress incontinence

1.8

8.8

139

807

WX723

NOMESCO Finland

CPAP therapy

2.1

8.8

366

M35.7

ICD-10 Finland

Hypermobility syndrome

3.5

8.8

P17

ICPC

Tobacco abuse

3.8

8.8

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.4

8.8

DFF15

NOMESCO Finland

Speech audiometry

2.0

8.8

517

R05DA01

ATC

ethylmorphine; oral

1.8

8.7

133

764

N02CC06

ATC

eletriptan; oral

2.2

8.7

321

C09CA03

ATC

valsartan; oral

1.7

8.7

160

969

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

7.2

8.7

A01AB10

ATC

natamycin; local oral

2.4

8.7

258

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.4

8.7

258

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.8

8.7

146

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

8.7

127

721

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

50.2

8.7

GEA00

NOMESCO Finland

Mediastinoscopy

50.2

8.7

D72.1

ICD-10 Finland

Eosinophilia

50.2

8.7

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.6

8.7

186

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.0

8.7

422

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

8.7

395

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

8.7

242

1625

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.2

8.7

342

ZX109, ,

SPAT

7.6

8.6

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

8.6

464

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

8.6

471

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

8.6

149

888

H15.1

ICD-10 Finland

Episcleritis

3.3

8.6

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.8

8.6

158

N03AF01

ATC

carbamazepine; oral, rectal

2.1

8.6

403

H03AA01

ATC

levothyroxine sodium; systemic

1.4

8.6

432

3252

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

11.6

8.6

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.9

8.5

515

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

8.5

175

1092

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.0

8.5

OAB42, ,

SPAT

1.5

8.5

277

1921

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

8.5

187

1187

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

8.5

419

3141

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

3.8

8.5

L16

ICPC

Ankle symptom/complaint

1.5

8.5

233

1558

Z3226

NOMESCO Finland

Physiotherapist

1.5

8.5

297

2091

EB1HA, ,

SPAT

2.3

8.5

255

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

20.1

8.5

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.3

8.5

274

H65.0

ICD-10 Finland

Acute serous otitis media

3.0

8.5

121

N02AJ13

ATC

tramadol and paracetamol; systemic

2.8

8.4

154

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

8.4

149

894

R55

ICD-10 Finland

Syncope and collapse

1.6

8.4

199

1286

J86.9

ICD-10 Finland

Pyothorax without fistula

90.3

8.4

DMB10

NOMESCO Finland

Radical maxillary antrotomy

90.3

8.4

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

90.3

8.4

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

8.4

184

1167

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.8

8.4

149

R25.2

ICD-10 Finland

Cramp and spasm

2.6

8.4

172

JN4AD

NOMESCO Finland

Body CT examination

1.6

8.3

175

1098

49308

ICD-8 Finland

Asthma, Alia definita

+∞

8.3

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

+∞

8.3

SPAT1267

SPAT

Desensitisation

+∞

8.3

R03DX10

ATC

benralizumab; systemic

+∞

8.3

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

+∞

8.3

51899

ICD-8 Finland

Bronchiectasis

+∞

8.3

J43.2

ICD-10 Finland

Centrilobular emphysema

+∞

8.3

3027

Kela drug reimbursment

Benralizumab

+∞

8.3

251, ,

Kela drug reimbursment

+∞

8.3

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

8.3

3028

Kela drug reimbursment

Mepolizumab

+∞

8.3

S20.2

ICD-10 Finland

Contusion of thorax

1.9

8.3

498

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.0

8.3

117

50708

ICD-8 Finland

Hay fever, Alia definita

8.5

8.3

R23

ICPC

Voice symptom/complaint

2.7

8.3

167

I47.2

ICD-10 Finland

Ventricular tachycardia

2.8

8.3

150

M02AA10

ATC

ketoprofen; topical

1.5

8.3

285

1999

SPAT1251

SPAT

Organisation of medication

2.2

8.3

296

J41.0

ICD-10 Finland

Simple chronic bronchitis

9.5

8.3

ZX108

NOMESCO Finland

Inhalation

9.5

8.3

P06

ICPC

Sleep disturbance

1.5

8.2

226

1511

M43.1

ICD-10 Finland

Spondylolisthesis

2.1

8.2

349

280

Kela drug reimbursment

Clopidogrel

3.2

8.2

XKD00

NOMESCO Finland

Uroflowmetry

1.5

8.2

266

1844

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

8.2

204

1335

L29.9

ICD-10 Finland

Pruritus, unspecified

2.3

8.2

253

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

2.1

8.2

357

SPAT1283

SPAT

Restricted health certificate

1.4

8.2

319

2294

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

8.1

187

1200

R52.1

ICD-10 Finland

Chronic intractable pain

4.5

8.1

P25

ICPC

Phase of life problem adult

2.0

8.1

433

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

3.5

8.1

SPAT1236

SPAT

Informing family of child’s disability

2.6

8.1

181

SXC05

NOMESCO Finland

Other oral or dental procedure

1.7

8.1

134

790

XKX00

NOMESCO Finland

Pelvic floor electromyography

8.1

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

17.2

8.1

R03BB05

ATC

aclidinium bromide; inhalant

17.2

8.1

S19

ICPC

Skin injury other

2.1

8.1

379

C01DA14

ATC

isosorbide mononitrate; oral

1.5

8.1

271

1892

R43

ICPC

Respiratory, Other diagnostic procedure

6.8

8.1

RF110, ,

NOMESCO Finland

8.9

8.0

AN2

Balloon angioplasty, including several vessels

2.4

8.0

218

ZX112

NOMESCO Finland

Subcutaneous

2.7

8.0

153

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.4

8.0

237

Z50.1

ICD-10 Finland

Other physical therapy

1.9

8.0

492

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

8.0

485

R01BA01

ATC

phenylpropanolamine; oral

2.0

7.9

464

N06AX22

ATC

agomelatine; oral

2.6

7.9

171

R5599

NOMESCO Finland

Other rehabilitation service

2.3

7.9

257

T91

ICPC

Vitamin/nutritional deficiency

4.4

7.9

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

7.9

1080

9352

F61.0

ICD-10 Finland

Mixed personality disorders

3.2

7.8

NF1AA, ,

SPAT

2.0

7.8

439

M01AX17

ATC

nimesulide; oral

1.4

7.8

402

3034

D09AB01

ATC

zinc bandage without supplements; topical

2.9

7.8

127

R07.0

ICD-10 Finland

Pain in throat

1.7

7.8

130

768

R60.1

ICD-10 Finland

Generalized oedema

7.0

7.8

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

7.7

228

1549

R03BB06

ATC

glycopyrronium bromide; inhalant

45.1

7.7

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

45.1

7.7

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

15.1

7.7

L15

ICPC

Knee symptom/complaint

1.4

7.7

484

3770

R06AE08, ,

ATC

4.3

7.7

OAB91, ,

SPAT

1.7

7.7

131

779

R06.4

ICD-10 Finland

Hyperventilation

3.4

7.7

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

7.6

360

XQ802

NOMESCO Finland

Epicutan test

2.1

7.6

340

R10.0

ICD-10 Finland

Acute abdomen

2.2

7.6

268

S97

ICPC

Chronic ulcer skin

1.8

7.6

101

558

C01BD01

ATC

amiodarone; systemic

2.5

7.6

187

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

11.9

7.6

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

7.6

309

2239

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

3.1

7.6

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.3

7.5

256

RJ410, ,

NOMESCO Finland

10.0

7.5

3007

Kela drug reimbursment

Erenumab and fremanezumab

3.2

7.5

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.1

7.5

335

N02CC04

ATC

rizatriptan; oral

1.9

7.5

538

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

7.5

265

1868

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

7.5

104

582

RJ411, ,

NOMESCO Finland

7.1

7.5

B34.9

ICD-10 Finland

Viral infection, unspecified

2.3

7.5

238

L04AX03

ATC

methotrexate; systemic

1.6

7.5

157

987

A10BJ06

ATC

semaglutide; parenteral

1.9

7.4

440

TGA30

NOMESCO Finland

Thoracocentesis

80.3

7.4

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

80.3

7.4

SPAT1081

SPAT

Cardiorespiratory global assessment

1.9

7.4

497

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

7.4

318

2325

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.4

7.4

214

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

7.4

101

563

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.0

7.3

A04

ICPC

Weakness/tiredness general

1.4

7.3

300

2174

L01CA04

ATC

vinorelbine; systemic

8.4

7.3

N30.0

ICD-10 Finland

Acute cystitis

1.4

7.3

333

2461

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

7.3

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

7.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

7.3

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

7.3

NOMESCO Finland

Other rehabilitation services

+∞

7.3

R03DX09

ATC

mepolizumab; parenteral

+∞

7.3

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

+∞

7.3

13599

ICD-8 Finland

Sarcoidosis, Unspecified

+∞

7.3

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

7.3

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

+∞

7.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

7.3

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

7.3

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

7.3

123

730

K02.1

ICD-10 Finland

Caries of dentine

1.3

7.2

1206

10647

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

7.2

114

663

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.4

7.2

374

2823

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

15.8

7.2

L86

ICPC

Back syndrome with radiating pain

1.8

7.2

106

604

S01GX04

ATC

nedocromil; ophthalmic

2.9

7.2

116

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

5.8

7.2

SPAT1262

SPAT

Handing over of treatment supplies

1.4

7.2

280

2011

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

7.2

254

1792

205

Kela drug reimbursment

Chronic hypertension

1.3

7.2

496

3917

F03

ICPC

Eye discharge

1.7

7.1

130

787

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

30.1

7.1

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

30.1

7.1

J12.8

ICD-10 Finland

Other viral pneumonia

30.1

7.1

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

7.1

439

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

3.1

7.1

Z2445

NOMESCO Finland

Psychologist

2.0

7.1

356

RS221, ,

NOMESCO Finland

3.5

7.1

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.4

7.1

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

7.9

7.1

J38.7

ICD-10 Finland

Other diseases of larynx

12.0

7.1

UDQ22

NOMESCO Finland

Microlaryngoscopy

12.0

7.1

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

7.1

244

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

7.1

491

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

8.8

7.0

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

7.0

765

6414

Y1202

ICD-8 Finland

Skin tests, Allergy tests

10.0

7.0

C02DE01, ,

ATC

3.6

7.0

S01

ICPC

Pain/tenderness of skin

1.9

7.0

456

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

4.2

7.0

L50.8

ICD-10 Finland

Other urticaria

2.8

7.0

118

R49.0

ICD-10 Finland

Dysphonia

2.8

7.0

118

S81.0

ICD-10 Finland

Open wound of knee

2.7

7.0

135

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

7.0

160

1028

F02

ICPC

Red eye

1.9

6.9

479

N01

ICPC

Headache

1.5

6.9

222

1534

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

6.9

229

1593

OAB93, ,

SPAT

1.7

6.9

115

679

KMAK, ,

NOMESCO Finland

1.3

6.9

992

8595

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

6.9

466

NG1AA, ,

SPAT

1.6

6.9

145

912

A28

ICPC

Limited function/disability NOS

1.4

6.9

305

2242

A10BA02

ATC

metformin; oral

1.3

6.9

504

4010

R03CC03

ATC

terbutaline; systemic

2.3

6.9

215

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

2.9

6.8

103

R4110

NOMESCO Finland

Physiotherapy

1.3

6.8

460

3614

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

6.8

150

953

N03AX11

ATC

topiramate; oral

2.5

6.8

166

S87

ICPC

Dermatitis/atopic eczema

2.3

6.8

228

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

6.8

540

K07.60

ICD-10 Finland

Snapping jaw

1.9

6.8

489

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

6.8

163

1057

PA6AD

NOMESCO Finland

CT of neck arteries

2.0

6.8

341

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

6.8

185

1235

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

3.0

6.8

A06AC51

ATC

ispaghula, combinations; oral

1.9

6.8

411

E66

ICD-10 Finland

Obesity

1.8

6.8

519

RJ421, ,

NOMESCO Finland

9.3

6.8

A11CC03

ATC

alfacalcidol; systemic

2.6

6.8

149

R05CB03

ATC

carbocisteine; oral

2.5

6.8

161

L12

ICPC

Hand/finger symptom/complaint

1.4

6.8

317

2353

SPAT1324

SPAT

Screening procedure

1.4

6.8

324

2414

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

40.2

6.8

J41.8

ICD-10 Finland

Mixed simple and mucopurulent chronic bronchitis

40.2

6.8

J31

ICD-10 Finland

Chronic rhinitis, nasopharyngitis and pharyngitis

3.6

6.7

L04AA01

ATC

[U] ciclosporin

3.6

6.7

RJ511, ,

NOMESCO Finland

16.7

6.7

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.2

6.7

262

R63.4

ICD-10 Finland

Abnormal weight loss

2.0

6.7

329

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.7

6.7

132

207

Kela drug reimbursment

Chronic arrhythmias

1.4

6.7

255

1822

OAA65, ,

SPAT

1.4

6.7

327

2442

A10BJ02

ATC

liraglutide; parenteral

2.4

6.7

186

N02CD01

ATC

erenumab; parenteral

3.9

6.7

RK112, ,

NOMESCO Finland

22.6

6.7

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.7

6.7

127

AA1AD

NOMESCO Finland

CT of head and brain

1.3

6.7

478

3790

R75

ICPC

Sinusitis acute/chronic

2.0

6.7

358

S30.1

ICD-10 Finland

Contusion of abdominal wall

3.0

6.6

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

6.6

508

4064

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

3.7

6.6

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.9

6.6

415

J06.0

ICD-10 Finland

Acute laryngopharyngitis

4.0

6.6

R00.2

ICD-10 Finland

Palpitations

1.6

6.6

141

890

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.6

6.6

159

1033

SPAT1211

SPAT

Application of soft bandage

1.6

6.6

158

1025

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.0

6.6

373

N05AF03

ATC

chlorprothixene; systemic

2.5

6.6

163

J05AB11

ATC

valaciclovir; oral

1.4

6.6

252

1804

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.8

6.6

111

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.2

6.6

245

OAB44

NOMESCO Finland

General health guidance

12.3

6.6

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

6.6

459

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

3.5

6.6

DHA10

NOMESCO Finland

Biopsy of cavity of nose

8.7

6.5

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

6.5

117

706

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

3.0

6.5

ZXA05

NOMESCO Finland

Left side

1.3

6.5

403

3125

A10BX04

ATC

[U] exenatide

3.8

6.5

R01AD

ATC

Corticosteroids

3.8

6.5

Z01.3

ICD-10 Finland

Examination of blood pressure

2.9

6.5

106

P01BA02

ATC

hydroxychloroquine; oral

1.7

6.5

127

784

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

6.5

154

998

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

6.5

483

M01AH03

ATC

valdecoxib; oral

1.8

6.5

557

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

6.5

136

856

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.4

6.5

177

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

70.0

6.4

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

70.0

6.4

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.4

6.4

288

2122

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

6.4

230

1627

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

6.4

121

741

Z29.0

ICD-10 Finland

Isolation

14.3

6.4

50503

ICD-8 Finland

Nasal polyp, Ethmoidalis

14.3

6.4

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

6.4

103

604

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

6.4

141

898

Z51.5

ICD-10 Finland

Palliative care

1.6

6.4

134

843

ZXA00

NOMESCO Finland

Right side

1.3

6.4

432

3396

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

6.4

249

1790

RF212, ,

NOMESCO Finland

6.0

6.3

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

2.0

6.3

324

-1, ,

ICPC

2.0

6.3

331

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.9

6.3

373

Z01.7

ICD-10 Finland

Laboratory examination

1.4

6.3

317

2382

J32.3

ICD-10 Finland

Chronic sphenoidal sinusitis

+∞

6.3

297, ,

Kela drug reimbursment

+∞

6.3

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

6.3

J01GB01

ATC

tobramycin; inhalant, parenteral

+∞

6.3

DPA20

NOMESCO Finland

Trephine of frontal sinus

+∞

6.3

GX1C5

NOMESCO Finland

PEF monitoring for assessment of efficacy of asthma management

+∞

6.3

284

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

6.3

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

+∞

6.3

A15.1

ICD-10 Finland

Tuberculosis of lung, confirmed by culture only

+∞

6.3

13597

ICD-8 Finland

Sarcoidosis, Suspecta

+∞

6.3

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

+∞

6.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

6.3

D86.3

ICD-10 Finland

Sarcoidosis of skin

+∞

6.3

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

6.3

D10

ICPC

Vomiting

1.7

6.2

111

669

H16.0

ICD-10 Finland

Corneal ulcer

1.8

6.2

489

D01AE15

ATC

terbinafine; topical

1.7

6.2

118

723

C10AC01

ATC

colestyramine; oral

2.2

6.2

218

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

6.2

231

1644

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.0

6.2

346

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.1

6.2

291

M41.9

ICD-10 Finland

Scoliosis, unspecified

2.9

6.2

S01GX09

ATC

olopatadine; ophthalmic

2.2

6.2

238

PLAK2, ,

NOMESCO Finland

3.7

6.2

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

6.2

1482

13519

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

6.3

6.2

S51.9

ICD-10 Finland

Open wound of forearm, part unspecified

3.5

6.2

XQ902

NOMESCO Finland

Other photography

3.2

6.1

SPAT1259

SPAT

Opinion on plain films

3.2

6.1

EC1VA, ,

NOMESCO Finland

1.8

6.1

536

R49.09

ICD-10 Finland

Unspecified dysphonia

3.3

6.1

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

6.1

405

R05DB20

ATC

other cough suppressants - combinations

1.7

6.1

567

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

6.1

133

845

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

6.1

154

1013

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

6.1

449

Z48.8

ICD-10 Finland

Other specified surgical follow-up care

3.8

6.1

M43.0

ICD-10 Finland

Spondylolysis

2.7

6.1

116

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

6.1

197

1366

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

12.5

6.1

M05BX04

ATC

denosumab; parenteral

1.7

6.1

103

613

C09AA02

ATC

enalapril; systemic

1.4

6.1

337

2570

K08.3

ICD-10 Finland

Retained dental root

1.6

6.1

122

760

XJC00

NOMESCO Finland

Oesophageal manometry

8.6

6.0

SPAT1308

SPAT

Sexual health counselling

1.4

6.0

235

1688

DM1QA, ,

SPAT

1.9

6.0

343

N06AA10

ATC

nortriptyline; systemic

2.6

6.0

134

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.5

6.0

140

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.5

6.0

J18

ICD-10 Finland

Pneumonia, organism unspecified

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

396

688

6.66

224.12

1.5

1.1

267.16

174.75

u/ml

1.70

384

630

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

51.94

165.34

1.4

1.0

1.57

2.30

u/ml

—

(3023419) Bacteria identified in Sputum by Culture

31.37

125.49

3.5

1.2

—

(3025159) Blasts/Leukocytes in Blood

414

1379

3.40

99.81

5.0

4.3

0.03

0.41

0.80

294

(3021440) Promyelocytes/Leukocytes in Blood

401

1342

3.37

95.72

4.5

4.2

0.04

0.11

1.16

288

(3017181) Myelocytes/Leukocytes in Blood

408

1385

3.33

95.14

4.5

4.1

0.62

0.81

0.65

331

(3010726) Horse dander IgE Ab [Units/volume] in Serum

145

215

7.10

93.79

1.2

1.0

2.31

1.26

u/ml

0.62

(3013115) Eosinophils [#/volume] in Blood

1403

8852

2.35

92.15

6.7

5.5

0.22

0.18

e9/l

11.44

1309

7601

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

121

150

8.43

91.37

3.3

2.0

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

271

738

4.00

87.79

1.7

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

43.36

85.17

4.3

2.8

—

(3001604) Monocytes [#/volume] in Blood

1346

8588

2.24

82.76

6.4

5.3

0.61

0.55

e9/l

14.44

1245

7243

(3006315) Basophils [#/volume] in Blood

1347

8608

2.24

82.35

6.5

5.3

0.04

e9/l

4.88

1246

7259

(3042631) Mycobacterium sp identified in Specimen

15.52

81.26

3.7

2.1

—

(3018010) Neutrophils/Leukocytes in Blood

1268

7968

2.21

80.07

6.2

5.4

57.50

56.22

3.73

1240

7564

(3002179) Metamyelocytes/Leukocytes in Blood

374

1330

3.13

79.93

4.1

3.9

0.49

0.75

0.88

322

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

148

265

5.87

79.45

1.2

1.1

2.35

2.75

u/ml

0.14

118

(3019198) Lymphocytes [#/volume] in Blood

1364

8873

2.19

78.31

6.4

5.4

1.96

1.94

e9/l

0.22

1284

7687

(3019069) Monocytes/Leukocytes in Blood

1248

7840

2.19

78.29

6.5

5.5

8.67

8.84

1.47

1209

7270

(3006504) Eosinophils/Leukocytes in Blood

1246

7825

2.19

78.20

6.4

5.4

3.14

2.81

4.27

1209

7245

(3000492) Spirometry study

352

1223

3.19

78.17

1.6

1.3

—

(3022096) Basophils/Leukocytes in Blood

1246

7842

2.18

77.56

6.4

5.5

0.69

0.19

1205

7254

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

10.31

73.70

1.9

1.3

—

(3002030) Lymphocytes/Leukocytes in Blood

1265

8148

2.13

72.53

6.5

5.4

27.61

29.15

6.01

1233

7636

(3003888) Timothy IgE Ab [Units/volume] in Serum

129

225

5.99

71.09

1.1

1.0

3.44

4.84

u/ml

0.55

102

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

19.07

71.02

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

743

3920

2.28

70.30

4.5

3.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

120

198

6.32

69.93

1.2

1.0

5.34

3.06

u/ml

0.68

(3008401) Mugwort IgE Ab [Units/volume] in Serum

125

223

5.85

67.27

1.1

1.0

0.47

2.14

u/ml

1.06

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

445

1920

2.61

65.37

2.2

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

101

170

6.15

57.65

1.1

1.0

0.26

0.23

u/ml

0.06

(3013650) Neutrophils [#/volume] in Blood by Automated count

1406

10036

1.93

54.04

9.2

7.9

4.35

3.92

e9/l

11.09

1304

8561

(3023368) Bacteria identified in Blood by Culture

662

3722

2.06

50.62

4.5

3.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

189

5.36

48.43

1.1

5.63

3.14

u/ml

0.80

(3036481) Cortisol [Moles/volume] in Serum or Plasma

324

1389

2.53

47.31

2.4

2.0

325.57

389.50

nmol/l

7.69

305

1286

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

12.42

44.47

1.2

1.1

11.95

17.44

u/ml

0.54

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

743

4603

1.88

41.42

3.4

2.7

1156.18

1319.08

ng/l

0.59

637

3931

(3021589) Normoblasts [#/volume] in Blood

1162

8260

1.77

40.81

13.5

9.2

0.00

e9/l

1.69

1041

6760

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

938

6291

1.79

40.05

4.0

3.0

28.88

56.68

ng/l

2.19

643

4203

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

296

1314

2.42

39.78

2.2

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

307

1388

2.38

39.59

2.3

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

179

626

3.00

38.50

3.0

3.6

1.76

1.58

0.70

174

588

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

813

5383

1.76

35.25

2.8

2.3

52.62

76.45

u/l

0.95

771

4951

(3027801) Oxygen [Partial pressure] in Arterial blood

314

1534

2.20

33.45

5.3

6.6

11.10

13.83

kpa

17.84

303

1485

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

314

1535

2.20

33.40

5.3

6.6

5.22

4.99

kpa

3.80

302

1485

(3032080) INR in Blood by Coagulation assay

1073

7807

1.66

32.00

13.3

12.8

1.21

1.25

inr

1.54

943

6399

(3005719) IgG [Mass/volume] in Serum or Plasma

238

1061

2.37

31.44

2.7

2.3

9.94

11.07

g/l

4.15

230

964

(3016502) Oxygen saturation in Arterial blood

284

1369

2.21

31.19

5.2

7.0

94.90

96.49

4.26

272

1327

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

144

508

2.95

30.44

2.1

1.2

39.75

38.98

u/l

0.16

132

452

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

168

4.51

30.21

1.5

1.2

—

(3019977) pH of Arterial blood

306

1538

2.13

30.19

5.4

6.6

7.42

7.41

0.95

198

794

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1197

9073

1.62

29.48

6.2

5.4

10.61

12.35

umol/l

6.69

1153

8599

(3019060) Gas panel - Arterial blood

174

702

2.59

28.44

3.6

4.0

—

(42870588) Differential panel, method unspecified - Blood

779

5359

1.66

27.98

6.5

5.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

6.10

27.66

1.4

1.1

—

(3003396) Base excess in Arterial blood by calculation

296

1519

2.08

27.54

5.5

6.6

1.81

0.32

mmol/l

9.72

251

1232

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

555

3500

1.75

27.41

2.0

1.6

0.93

1.27

mg/l

2.55

433

2646

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1658

13738

1.62

27.16

5.3

3.6

12.62

10.72

mm/h

5.93

1603

12784

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

134

484

2.87

27.13

2.2

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

146

4.54

26.90

1.4

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1343

10615

1.58

26.62

5.1

3.8

6.39

6.58

mmol/l

3.50

1286

9857

(3017569) Oxygen content in Arterial blood

7.40

26.30

1.7

1.5

16.89

16.33

0.37

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

9.78

25.89

4.7

2.7

—

(3009343) pH of Capillary blood

180

783

2.40

25.02

3.7

2.9

7.41

0.13

163

644

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

116

406

2.95

24.87

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

145

575

2.62

24.53

3.2

3.7

0.76

0.87

2.86

138

539

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

105

5.04

24.44

1.4

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

771

5438

1.61

24.35

3.6

2.9

0.01

0.39

estimate

1.04

299

1578

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

497

3132

1.73

24.27

1.4

1.3

27.87

28.32

iu/ml

0.03

143

947

(3024139) IgG subclass 3 [Mass/volume] in Serum

5.36

24.20

1.5

1.3

0.32

0.43

g/l

1.72

(3027135) IgG subclass 1 [Mass/volume] in Serum

5.36

24.20

1.5

1.3

6.10

7.25

g/l

1.21

(3028192) IgG subclass 2 [Mass/volume] in Serum

5.36

24.20

1.5

1.3

2.63

3.31

g/l

1.69

(3017732) Neutrophils [#/volume] in Blood

366

2110

1.86

24.11

3.4

3.0

4.72

4.70

e9/l

0.01

335

1833

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

188

3.86

23.68

1.5

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

376

2200

1.84

23.59

1.5

1.3

397.58

553.10

titre

1.20

458

(3028026) IgM [Mass/volume] in Serum or Plasma

187

849

2.30

23.56

1.7

1.8

1.31

1.37

g/l

0.16

179

776

(4062490) Immunoglobulin typing, IgG

5.24

23.16

1.6

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

136

4.34

22.77

1.4

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

277

3.26

22.62

1.9

1.2

10.21

11.15

mg/l

0.45

260

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

158

685

2.39

22.11

1.8

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

118

447

2.72

21.85

2.2

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

177

811

2.27

21.81

4.5

5.6

25.45

23.94

mmol/l

4.55

172

778

(3045424) Erythrocytes [Presence] in Urine

182

850

2.23

21.42

2.0

0.00

0.01

estimate

0.69

116

290

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1119

8760

1.51

21.31

7.6

5.5

1.22

mmol/l

0.11

1008

7494

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

156

691

2.34

20.80

3.6

2.8

2.52

0.99

mmol/l

6.63

105

467

(3007853) Bacteria identified in Skin by Aerobe culture

314

1812

1.84

20.44

2.0

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1655

14142

1.51

19.89

8.4

6.5

77.10

78.72

u/l

0.99

1608

13286

(3042936) Bacteria identified in Isolate by Culture

341

2040

1.78

19.66

2.2

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

330

2.89

19.49

2.2

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

5.80

19.30

1.5

1.6

7.50

9.44

mmol/l

1.52

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

247

1361

1.90

18.52

3.7

3.3

1.23

mmol/l

0.40

232

1137

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

134

3.94

18.06

1.3

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

134

3.94

18.06

1.3

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

104

4.39

18.03

1.6

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1001

7877

1.45

17.43

5.1

4.1

35.66

36.29

g/l

3.09

951

7351

(3021447) Carbon dioxide [Partial pressure] in Venous blood

269

1557

1.82

17.23

3.8

3.1

6.01

5.68

kpa

4.52

261

1510

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

195

1021

1.99

16.97

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

424

2800

1.62

16.73

2.8

2.3

13.62

13.73

umol/l

0.07

401

2593

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

4.92

16.15

1.6

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1082

8723

1.43

16.12

2.7

2.3

77.09

77.43

nmol/l

0.16

1032

7934

(44813793) Dust mix specific IgE antibody measurement

4.58

16.11

1.1

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

434

2908

1.60

16.08

1.4

1.3

7.34

11.08

u/ml

1.01

230

1205

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

366

2354

1.65

16.01

2.9

2.3

23.27

23.53

0.11

344

2174

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

200

1080

1.93

15.90

3.9

2.5

113.91

206.65

ng/l

5.75

180

977

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

708

5287

1.47

15.83

2.1

2.0

159.60

207.67

u/l

1.22

678

4986

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

5.89

15.71

1.1

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

5.89

15.71

1.1

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

5.89

15.71

1.1

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

391

2568

1.62

15.71

2.8

2.3

2.45

2.33

g/l

4.03

372

2357

(3026782) Osmolality of Urine

480

3310

1.56

15.67

3.1

2.6

515.35

540.47

mosm/kgh2o

1.61

438

2841

(3008037) Lactate [Moles/volume] in Venous blood

407

2.49

15.59

2.2

2.4

1.41

1.62

mmol/l

2.14

391

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

402

2.50

15.51

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

246

1436

1.79

15.27

2.5

2.2

0.39

0.38

e6/l

0.04

237

1366

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

4.77

15.18

1.7

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

966

7691

1.42

15.15

4.0

3.4

0.01

0.09

estimate

0.80

289

1647

(3007164) IgA [Mass/volume] in Serum or Plasma

527

3738

1.52

15.06

1.5

1.4

2.28

2.30

g/l

0.07

396

2287

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

16.57

14.75

1.3

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

196

3.11

14.59

1.5

0.64

0.83

g/l

1.04

153

(3029937) Albumin [Presence] in Urine by Test strip

735

5600

1.44

14.57

4.3

3.5

0.01

0.00

estimate

0.19

383

1883

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

402

2.44

14.55

1.7

0.91

3.30

ug/l

1.40

343

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

197

3.10

14.47

1.2

105.71

298.82

titre

—

(3000850) Epithelial cells [#/volume] in Urine

539

3884

1.50

14.17

2.6

2.4

5.45

5.92

e6/l

0.44

511

3475

(3047181) Lactate [Moles/volume] in Blood

384

2.45

14.05

4.4

4.3

1.35

1.25

mmol/l

0.34

328

(40768797) Stomach Pathology biopsy report

348

2282

1.61

13.97

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

446

3111

1.53

13.64

3.9

3.1

130.20

546.07

ng/l

3.40

276

2318

(3026493) Urate [Moles/volume] in Serum or Plasma

592

4385

1.46

13.45

2.8

2.3

342.21

333.54

umol/l

1.32

553

3894

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

6.33

13.28

1.5

1.1

—

(44790049) Parainfluenza type 3 nucleic acid detection

4.04

13.09

1.5

1.1

—

(44806118) Parainfluenza type 4 nucleic acid detection

4.04

13.09

1.5

1.1

—

(44790048) Parainfluenza type 2 nucleic acid detection

4.04

13.09

1.5

1.1

—

(44790047) Parainfluenza type 1 nucleic acid detection

4.04

13.09

1.5

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

330

2.50

13.05

1.2

1.1

4.79

5.06

0.09

(4015189) Microbial culture of sputum

19.13

12.90

2.7

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

741

5766

1.41

12.72

3.5

2.9

103.15

109.51

e6/l

0.04

607

4293

(3021601) Nitrite [Presence] in Urine by Test strip

1195

10053

1.36

12.70

4.1

3.4

0.00

estimate

0.80

395

2033

(3024354) Oxygen [Partial pressure] in Venous blood

225

1356

1.72

12.47

3.7

2.7

4.68

4.54

kpa

0.28

218

1316

(1616796) Gas panel - Central venous blood

246

2.69

12.17

2.4

2.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

224

2.77

12.10

1.6

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

3.95

12.00

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1128

9461

1.35

11.96

3.4

2.8

108.73

106.67

ug/l

0.09

1078

8864

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.26

11.73

1.9

2.0

—

(3000494) Fungus identified in Specimen by Culture

295

1936

1.59

11.72

1.5

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

1207

10253

1.34

11.65

4.1

3.5

0.00

0.16

estimate

0.55

372

1997

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

4.85

11.42

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

5.40

11.34

1.1

1.59

6.61

u/ml

0.51

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

627

4819

1.40

11.34

2.5

2.2

2.90

2.75

mg/l

0.96

570

4136

(3014576) Chloride [Moles/volume] in Serum or Plasma

313

2099

1.56

11.32

5.6

6.0

103.94

104.76

mmol/l

2.37

313

2099

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

757

6005

1.37

11.31

3.2

2.8

32.93

32.56

u/l

0.04

720

5672

(3039000) Anion gap in Blood by calculation

256

2.58

11.27

4.3

5.4

11.17

11.53

mmol/l

0.35

225

(3018572) Chloride [Moles/volume] in Blood

257

2.57

11.19

4.3

5.3

103.62

105.70

mmol/l

3.09

226

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

5.75

11.00

1.2

1.8

1.20

1.18

mmol/l

0.98

(40768806) Pleura Pathology biopsy report

5.42

10.87

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

1191

10197

1.32

10.45

4.1

3.4

0.00

3.67

estimate

1.58

405

2088

(3045414) Leukocytes [Presence] in Urine

268

1767

1.58

10.41

2.1

2.0

0.00

0.01

estimate

0.78

124

374

(3002032) Base excess in Venous blood by calculation

236

1513

1.62

10.31

4.0

3.1

2.31

1.36

mmol/l

2.93

205

1291

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1383

12115

1.32

10.20

3.6

2.9

—

(3026008) Bacteria identified in Urine by Culture

712

5669

1.36

10.19

3.2

2.9

—

(3022145) Colonoscopy Study observation

290

1961

1.54

10.07

1.3

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

3.51

9.89

1.1

1.0

4.72

13.65

iu/ml

1.41

(3012441) Differential panel - Pleural fluid

4.80

9.53

1.1

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

107

565

1.93

9.16

1.4

1.2

0.19

0.66

u/ml

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

4.43

9.08

1.5

1.1

—

(3012544) pH of Venous blood

238

1577

1.56

9.04

4.0

3.1

7.38

0.15

160

881

(3022313) Gas panel - Capillary blood

108

575

1.92

9.03

3.9

3.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

249

2.40

8.91

1.2

1.1

8.12

14.93

au/ml

0.77

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1680

15253

1.31

8.90

4.5

4.1

14.80

14.68

pmol/l

1.20

1582

13943

(3018095) Leukocytes [#/volume] in Urine

829

6863

1.31

8.82

4.1

3.4

119.55

112.17

e6/l

0.07

649

4563

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

501

3855

1.38

8.71

1.8

1.7

58503840.88

30156681.30

pmol/l

0.43

441

3200

(3048689) Calprotectin [Mass/mass] in Stool

338

2437

1.45

8.53

2.6

2.4

117.85

126.55

ug/g

0.22

268

1924

(3015377) Calcium [Moles/volume] in Serum or Plasma

764

6287

1.31

8.40

3.1

2.9

2.35

2.36

mmol/l

0.77

709

5731

(3011985) Renin [Units/volume] in Plasma

219

2.45

8.40

1.6

1.4

28.96

70.47

mu/l

1.49

195

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

6.71

8.35

1.1

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

6.71

8.35

1.1

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

6.71

8.35

1.1

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

6.71

8.35

1.1

1.3

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

3.22

8.21

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

182

2.56

8.00

1.3

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1399

12491

1.27

7.95

4.9

4.1

703.87

1826.29

e6/l

0.93

165

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

6.59

7.88

1.6

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

6.59

7.88

1.6

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

3.60

7.85

1.6

1.5

—

2.75

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2044

19205

1.37

7.82

19.5

10.7

20.01

22.10

mg/l

2.61

1824

14828

(21494815) CD4 cells/Lymphocytes in Specimen

3.49

7.81

1.4

2.2

41.08

40.48

0.06

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

346

2.08

7.65

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

163

2.60

7.60

1.5

1.6

23.08

29.93

ng/l

0.35

163

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

8.04

7.59

1.6

1.4

16.00

14.55

u/l

0.22

(3048929) Epstein Barr virus Ab [Presence] in Serum

497

1.88

7.41

1.3

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

343

2545

1.40

7.34

3.3

2.9

0.82

0.83

mmol/l

0.12

322

2386

(3014111) Lactate [Moles/volume] in Serum or Plasma

197

1314

1.54

7.28

7.1

6.4

1.40

1.38

mmol/l

0.08

191

1292

(3015076) Soybean IgE Ab [Units/volume] in Serum

3.20

7.11

1.0

0.68

5.40

u/ml

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

4.21

7.01

1.3

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

160

2.52

6.84

1.1

2.98

5.26

—

(3018418) pH of Serum or Plasma

625

5123

1.29

6.84

4.7

3.4

7.40

0.09

483

3577

(3014599) Egg white IgE Ab [Units/volume] in Serum

3.03

6.77

1.0

1.1

0.55

0.39

u/ml

0.28

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

561

4550

1.30

6.63

1.3

1.49

1.76

u/ml

0.28

202

1229

(3003329) Lymphocytes/Leukocytes in Synovial fluid

128

2.68

6.57

1.6

1.5

31.81

28.74

0.14

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

225

1580

1.47

6.50

2.4

2.2

0.21

g/l

0.30

214

1475

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

418

1.89

6.48

1.3

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

247

2.17

6.45

5.6

4.2

139.50

317.32

iu/ml

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

280

2067

1.40

6.16

6.3

4.5

1.09

1.04

mmol/l

1.98

259

1904

(3030467) Casts [#/volume] in Urine by Automated count

597

4925

1.28

6.12

3.3

2.8

0.57

0.38

e6/l

1.03

475

3527

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.47

6.00

1.4

—

(3014891) Appearance of Pleural fluid

15.04

5.90

1.7

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

5.03

5.87

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

5.03

5.87

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

5.03

5.87

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

5.03

5.87

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1416

12920

1.22

5.63

3.3

2.9

46.06

41.97

u/l

1.31

1360

12175

(3020630) Protein [Mass/volume] in Serum or Plasma

175

1207

1.48

5.56

1.9

2.1

67.00

67.01

g/l

0.01

160

1079

(3012501) Base excess in Blood by calculation

249

2.07

5.56

4.6

2.5

2.42

2.13

mmol/l

0.34

138

(3028308) Erythrocytes [#/volume] in Pleural fluid

3.63

5.48

1.2

40696.67

7604.41

e6/l

1.09

(3020874) Milk IgE Ab [Units/volume] in Serum

2.78

5.46

1.0

1.1

1.12

0.45

u/ml

0.58

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

488

1.75

5.43

1.5

0.16

0.12

iu/ml

0.11

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

447

3606

1.29

5.41

3.1

2.7

2.46

2.44

mmol/l

1.52

404

3236

(3006184) Hemoglobin [Mass/volume] in Capillary blood

303

1.94

5.26

1.6

1.8

135.22

130.62

g/l

0.63

253

(3025941) Bacteria identified in Stool by Culture

137

921

1.52

4.96

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

880

7730

1.21

4.92

6.9

5.1

1.21

1.22

mmol/l

0.81

827

7077

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.75

4.77

1.1

1.12

14.79

nmol/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

427

3480

1.27

4.73

1.8

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

182

1307

1.42

4.72

7.4

5.9

10.09

9.60

mmol/l

0.40

175

1251

(3008536) Aspergillus sp Ab [Presence] in Serum

14.03

4.57

1.3

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.60

4.47

1.9

1.8

3.75

2.94

u/field

0.11

(3023323) Follitropin [Units/volume] in Serum or Plasma

146

1020

1.46

4.40

1.5

1.4

22.40

26.54

iu/l

0.93

129

860

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

155

2150

0.70

4.38

6.4

5.9

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.10

4.36

4.0

1.5

524.82

1421.33

u/ml

1.16

(3004588) Protein electrophoresis panel - Serum or Plasma

145

1015

1.45

4.33

1.8

1.9

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

475

1.66

4.32

2.1

2.5

27.75

46.33

mg/l

2.14

411

(3011897) Casein IgE Ab [Units/volume] in Serum

5.52

4.28

1.1

1.2

0.59

0.48

u/ml

0.07

(3034860) Kappa light chains.free [Mass/volume] in Serum

477

1.66

4.26

2.1

2.5

52.59

52.77

mg/l

0.00

409

(3019550) Sodium [Moles/volume] in Serum or Plasma

2036

19512

1.24

4.10

20.3

13.6

139.48

139.78

mmol/l

5.77

2013

19007

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

155

1111

1.42

4.09

3.1

3.5

4.41

4.53

pmol/l

1.06

148

987

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.72

4.08

1.5

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

475

1.64

4.08

3.5

1.53

1.39

mg/l

0.80

429

(3023103) Potassium [Moles/volume] in Serum or Plasma

2040

19559

1.24

4.06

20.5

13.7

3.97

3.96

mmol/l

0.13

2019

19011

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

182

2.05

4.04

1.4

—

nmol/l

—

(3023420) DNA double strand Ab [Units/volume] in Serum

604

1.56

3.99

1.8

1.6

6.50

7.96

iu/ml

0.12

140

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1929

18422

1.21

3.80

17.9

11.7

83.66

82.31

ml/min/173m2

1.93

1813

16762

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

12.02

3.76

1.0

0.00

0.16

u/ml

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

401

1.66

3.73

3.5

3.4

0.35

0.36

iu/ml

0.18

217

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1597

16865

0.85

3.60

21.7

15.1

331.77

332.54

g/l

2.78

1584

16748

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

166

1233

1.37

3.59

4.0

3.4

87.49

82.61

ng/l

0.28

141

1074

(3006571) Granulocytes/Leukocytes in Synovial fluid

164

2.03

3.54

1.8

1.7

67.73

60.96

0.46

105

(3034274) Bile acid [Moles/volume] in Serum --fasting

293

1.76

3.54

1.8

2.3

5.10

8.25

umol/l

0.77

214

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

301

1.74

3.52

1.6

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

272

2176

1.28

3.50

1.5

1.4

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

6.17

3.50

1.6

1.0

90.88

95.31

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.88

3.48

2.2

1.9

9.02

10.87

kpa

1.27

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.88

3.48

2.2

1.9

5.58

4.41

kpa

3.26

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

3.88

3.48

1.0

21.60

53.89

iu/ml

1.45

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

417

1.62

3.48

2.0

2.3

2.42

2.83

ratio

0.14

230

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

356

1.67

3.45

1.2

3.62

3.64

mmol/l

0.08

335

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

242

1911

1.29

3.45

2.8

2.4

7.95

8.99

umol/l

0.33

211

1674

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

380

1.65

3.42

1.3

1.4

317.08

10947.30

e6/l

0.54

298

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

272

2185

1.27

3.39

1.7

1.49

1.39

1.74

242

1949

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.45

3.38

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

101

2.29

3.36

1.1

1.6

65.39

80.85

umol/l

3.34

101

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

715

0.57

3.32

1.2

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.72

3.32

1.4

1.3

191.84

155.94

mmol/24h

0.92

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.43

3.31

2.2

3.4

0.64

0.61

mmol/l

0.54

(3004809) Band form neutrophils/Leukocytes in Blood

204

1.88

3.30

3.8

3.5

3.15

1.51

0.67

183

(3045788) Cell count panel - Pleural fluid

2.93

3.29

1.3

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

408

1.61

3.28

1.5

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.39

3.22

1.1

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

199

1.87

3.20

1.2

1.4

0.18

0.19

nmol/l

0.41

157

(3003327) Ova and parasites identified in Stool by Light microscopy

620

1.49

3.20

1.4

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

3.54

3.19

1.9

1.8

0.44

0.26

e9/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

188

2404

0.76

3.15

1.7

1.9

3.63

3.40

ratio

1.38

134

1812

(3005570) Glucose [Moles/volume] in Urine

193

1.88

3.15

2.5

1.9

—

(1002224) Polysomnography panel

111

789

1.43

3.14

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

343

1.65

3.13

2.3

2.4

7.02

7.54

mmol/l

1.02

331

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

607

1.48

3.12

2.0

1.7

3.55

3.72

g/l

0.58

543

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

607

1.48

3.12

2.0

1.7

4.34

4.23

g/l

0.84

542

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

607

1.48

3.12

2.0

1.7

7.26

7.29

g/l

0.08

542

(40768804) Tissue Pathology biopsy report

835

7533

1.16

3.11

2.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

337

1.65

3.07

1.2

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

7.51

3.05

1.0

—

(21494814) CD8 cells/Lymphocytes in Specimen

3.34

3.01

1.6

2.1

27.25

27.42

0.01

(3027944) Amphetamines [Presence] in Urine

126

923

1.38

3.01

1.9

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

127

932

1.38

3.00

1.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

506

1.52

3.00

2.0

778.45

938.59

ug/l

0.08

483

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.75

2.98

1.1

1.2

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

10.01

2.98

1.0

1.2

0.49

0.12

u/ml

—

(3021960) Folate [Moles/volume] in Serum or Plasma

600

5291

1.18

2.96

1.6

19.79

20.73

nmol/l

0.78

537

4452

(3014051) Protein [Presence] in Urine by Test strip

610

5387

1.18

2.96

2.7

0.00

0.04

—

146

(3017446) Testosterone [Moles/volume] in Serum or Plasma

181

1406

1.31

2.95

2.6

2.2

11.68

12.30

nmol/l

0.50

158

1274

(3018677) aPTT in Platelet poor plasma by Coagulation assay

298

2463

1.24

2.93

2.2

1.9

29.10

29.41

0.51

292

2401

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

170

2180

0.76

2.92

4.8

4.7

32.35

32.66

0.14

117

1440

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

641

1.45

2.92

1.7

1.6

11.86

16.47

u/ml

0.60

169

(3024932) HLA-DR beta [Type]

3.71

2.88

1.0

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.60

2.87

1.9

2.2

8.83

9.10

mg/l

0.06

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

528

1.49

2.86

2.2

1.8

0.84

0.96

g/l

0.09

443

(3006922) Hepatitis E virus Ab [Presence] in Serum

109

2.12

2.84

1.0

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

347

1.60

2.77

1.3

12.37

1.86

u/ml

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

574

1.46

2.75

2.1

1.7

2.63

2.86

g/l

1.57

510

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

106

768

1.40

2.73

2.2

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

436

1.53

2.73

1.3

2.47

8.11

u/ml

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

458

3982

1.18

2.67

2.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

423

1.53

2.65

1.3

513.50

526.05

mg/l

0.06

400

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1719

16436

1.15

2.60

23.2

14.4

13.78

13.46

19.49

1706

16155

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

216

1746

1.26

2.60

3.6

4.1

5.00

41.36

ug/l

1.19

190

1403

(3052592) Norovirus Ag [Presence] in Stool

4.68

2.59

2.3

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

442

1.51

2.58

2.3

1.7

0.02

0.01

g/l

0.32

390

(3028300) Cannabinoids [Presence] in Urine

125

940

1.35

2.58

1.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

435

1.51

2.55

1.3

7.60

2.75

u/ml

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.87

2.54

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.43

2.54

1.2

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

902

8279

1.14

2.53

2.0

95.87

96.76

pmol/l

0.24

504

4295

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

186

1.78

2.53

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

560

1.44

2.52

1.7

1.4

9.44

8.77

u/l

0.19

445

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.23

2.51

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

262

1.65

2.51

1.5

1.4

63.06

65.87

mmol/l

0.18

213

(3003129) Base excess in Capillary blood by calculation

115

2.01

2.50

3.3

1.7

1.34

-0.11

mmol/l

1.11

109

(3027008) Opiates [Presence] in Urine

124

938

1.34

2.47

1.9

1.8

—

(21494755) Public health laboratory ask at order entry panel

241

1986

1.24

2.46

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

256

1.65

2.45

1.3

18.74

23.09

u/l

0.51

215

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.67

2.45

1.3

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

325

2763

1.20

2.44

3.4

2.7

4.44

2.57

e6/l

1.52

189

1337

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

375

1.53

2.43

1.2

1.4

18.89

18.73

e6/l

0.00

274

(3042733) HLA Ab [Presence] in Serum

3.13

2.43

4.8

3.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

145

1.87

2.41

4.1

4.0

7.77

6.76

mmol/l

0.31

121

(3024471) HLA-A [Type]

3.34

2.39

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

283

1.60

2.34

1.7

1.3

169.93

148.06

au/ml

0.70

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

149

1169

1.29

2.31

2.2

2.4

32.79

20.19

au/ml

0.53

149

(3000570) Elastase.pancreatic [Mass/mass] in Stool

471

1.46

2.29

1.5

1.3

292.84

289.20

ug/g

0.05

256

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

975

9040

1.13

2.28

2.8

2.5

—

estimate

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

654

0.64

2.26

1.7

—

(3022689) Creatine [Moles/volume] in Urine

2.28

2.24

1.2

1.3

6.55

9.01

mmol/l

0.88

(3007566) Smooth muscle Ab [Titer] in Serum

474

1.45

2.22

1.1

1.2

51.43

83.19

titre

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

287

1.58

2.22

3.3

3.1

0.76

0.82

nmol/l

0.55

226

(3009508) Creatinine [Moles/volume] in Urine

710

6462

1.14

2.22

3.2

3.3

7.58

7.57

mmol/l

0.02

638

5495

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1882

18179

1.15

2.22

5.6

5.0

1.90

1.92

mu/l

0.15

1785

16835

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

162

1293

1.27

2.21

2.0

2.1

3.99

7.81

ug/l

6.00

146

1138

(4281824) Cell count and differential, peritoneal fluid

210

0.43

2.19

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

143

1.83

2.18

1.2

103.19

106.73

pmol/l

0.14

143

(3023511) Choriogonadotropin [Units/volume] in Urine

428

1.46

2.14

1.6

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.63

2.14

1.0

0.22

3.19

u/ml

0.71

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

152

1.78

2.12

1.0

—

(3016879) Cocaine [Presence] in Urine

112

858

1.32

2.09

1.8

1.9

—

(3035715) Granulocytes [#/volume] in Blood

221

1.64

2.09

3.0

3.6

4.03

3.62

e9/l

0.89

221

(3000991) Gas panel - Venous blood

160

1285

1.26

2.09

7.7

7.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

738

8027

0.88

2.08

1.8

1.43

1.30

mmol/l

3.47

647

6828

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.01

2.07

1.6

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

123

957

1.30

2.06

1.1

147.14

119.83

titre

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.51

2.05

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

139

1.81

2.05

1.3

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

293

2510

1.19

2.04

2.2

2.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.01

2.04

1.5

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

257

2177

1.20

2.03

1.6

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

443

1.43

2.00

1.3

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

145

1800

0.79

1.99

1.6

1.7

3.49

3.44

mmol/l

0.17

1218

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

178

1.69

1.98

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

2.29

1.97

2.5

2.6

42.25

38.46

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

106

1.89

1.90

1.2

1.1

30.01

18.45

u/ml

—

(3011288) Drugs identified in Urine by Screen method Nominal

653

1.34

1.89

2.5

2.4

—

(1761868) Lipid panel - Serum or Plasma

850

7887

1.12

1.89

2.7

2.9

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.19

1.88

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

367

1.45

1.84

1.9

1.7

199.81

196.06

pmol/l

0.11

344

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

326

1.48

1.84

1.3

1.2

—

101.22

—

(40757373) Influenza virus identified in Isolate

4.17

1.82

1.6

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

368

1.45

1.82

2.1

2.3

117.82

71.85

ug/min

0.43

216

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.13

1.81

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

270

1.53

1.81

1.7

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

521

1.37

1.80

2.2

1.6

10.27

10.33

g/l

0.04

453

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.05

1.80

1.0

1.1

—

(44806420) Estimation of glomerular filtration rate

234

0.47

1.79

2.3

2.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

239

1.56

1.78

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

247

1.55

1.78

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

304

1.49

1.78

1.3

1.2

229.17

239.92

u/ml

0.13

184

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

131

1.76

1.77

1.3

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.92

1.72

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

314

2748

1.16

1.71

2.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

529

0.66

1.71

1.6

1.5

61.27

59.63

ug/l

0.09

529

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

167

1382

1.22

1.71

1.3

1.2

135.96

130.95

u/ml

0.05

525

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

187

1.61

1.69

1.3

—

(3037756) Immunofixation for Serum or Plasma

284

1.49

1.67

1.3

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.16

1.66

1.3

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.16

1.66

1.3

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.16

1.66

1.3

1.5

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.59

1.66

1.1

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

260

1.51

1.65

1.1

2.22

3.29

eliau/ml

0.29

121

(3021387) Prolactin [Units/volume] in Serum or Plasma

775

1.29

1.64

1.7

291.24

293.35

mu/l

0.03

711

(3019150) Specific gravity of Urine by Refractometry

507

4602

1.13

1.63

3.9

3.6

1.02

1.70

kg/l

0.80

352

2967

(3019309) Folate [Moles/volume] in Red Blood Cells

328

2893

1.15

1.62

1.6

1.7

1225.95

1143.52

nmol/l

0.86

259

2202

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.58

1.61

40.8

9.2

5.16

5.91

mmol/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

159

1.64

1.59

1.8

2.0

1.08

1.28

u/field

0.13

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

422

1.38

1.58

2.4

1.7

0.00

g/l

-0.00

368

(40768441) Liver Pathology biopsy report

137

1.68

1.55

1.2

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

184

1.58

1.54

1.3

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.60

1.51

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.60

1.51

1.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1856

18053

1.11

1.50

6.2

5.7

39.12

38.45

mmol/mol

3.14

1788

16928

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

1.95

1.48

1.3

1.1

—

(3008898) HLA-B27 [Presence]

619

1.30

1.47

1.0

1.1

—

(40768443) Skin Pathology biopsy report

788

1.27

1.47

1.2

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.50

1.45

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

644

5963

1.11

1.45

3.7

4.0

8.54

7.00

mg/mmol

0.36

434

3633

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

525

1.32

1.44

2.0

2.2

2.16

4.01

iu/l

2.72

228

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.42

1.39

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

264

1.45

1.36

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.83

1.35

2.9

2.0

0.89

1.51

u/ml

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

112

1.70

1.35

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

143

1.61

1.35

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

169

1440

1.19

1.33

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

376

1.36

1.32

1.1

1.3

—

(3035933) Granulocytes/Leukocytes in Blood

300

1.41

1.31

2.9

3.3

58.56

57.54

0.25

300

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.50

1.30

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

343

1.38

1.30

2.8

2.4

—

(3020393) Adenovirus Ag [Presence] in Stool

2.78

1.28

1.4

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.09

1.27

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

2.09

1.27

2.7

2.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

186

1.51

1.26

1.3

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.40

1.24

1.5

1.2

5.87

5.77

mmol/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

123

1.63

1.24

1.1

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

726

1.25

1.23

2.2

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

166

1428

1.17

1.19

2.2

2.4

73.93

67.62

e9/l

1.41

132

1041

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.31

1.18

1.2

1.9

15.67

28.07

pmol/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

482

1.29

1.16

1.1

1.54

5.82

eliau/ml

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.50

1.15

1.0

1.3

—

(44806071) Cardiolipin IgM antibody measurement

2.50

1.15

1.2

1.0

—

(3027945) Reticulocytes/Erythrocytes in Blood

212

1864

1.15

2.5

2.4

1.84

1.73

0.75

192

1650

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

126

1.59

1.14

1.3

1.0

299.40

246.51

mg/l

0.37

107

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

112

1334

0.83

1.13

1.5

1.6

1113.84

987.97

mu/l

0.71

1143

(4035726) Immunohistochemistry procedure

165

1427

1.17

1.12

1.2

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

1.71

1.11

1.4

1.7

0.81

1.25

nmol/l

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

701

1.23

1.10

1.6

1.7

1.52

1.47

g/l

0.22

598

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

109

911

1.21

1.09

2.3

2.1

5386.41

6049.86

u/l

0.09

368

(3014765) Yersinia sp identified in Stool by Organism specific culture

442

1.30

1.09

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.38

1.09

1.2

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.82

1.09

1.1

—

(3015736) pH of Urine

846

8029

1.08

3.4

3.0

6.18

6.25

1.01

515

4453

(3024263) Appearance of Synovial fluid

1.76

1.06

1.8

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.12

1.05

1.0

1.2

—

(3003694) ABO and Rh group [Type] in Blood

576

6142

0.92

1.03

1.6

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

190

1673

1.15

1.03

2.0

2.1

—

(3006270) Folate [Moles/volume] in Blood

151

0.53

1.02

1.1

396.75

339.60

nmol/l

—

136

(42529406) Shigella sp [Presence] in Stool by Culture

447

1.28

1.02

1.2

—

(3000012) Reticulocyte production index

238

1.39

1.02

1.2

2.0

0.98

0.87

0.23

158

(3038177) Helicobacter pylori Ab [Presence] in Serum

281

1.36

1.02

1.3

1.2

—

(3012516) Albumin [Mass/volume] in Urine

626

5883

1.09

1.02

3.2

3.4

65.04

37.59

mg/l

1.01

415

3626

(3049717) Cytology report of Urine Cyto stain

654

1.23

1.01

3.6

2.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

439

1.28

1.01

1.3

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

360

1.31

1.00

1.4

2.1

0.90

0.74

nmol/l

0.99

307

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

483

0.74

1.00

1.5

64.35

137.81

pmol/l

1.48

472

(3000475) Leukocytes [#/volume] in Synovial fluid

387

1.30

0.99

1.6

7159.64

13727.01

e6/l

1.14

262

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

131

0.53

0.98

1.0

1.4

—

1192.35

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

257

1.37

0.98

1.2

1.3

5.23

4.10

u/ml

0.11

(40759836) Histone Ab [Presence] in Serum by Immunoblot

124

1.54

0.96

1.3

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

100

1.60

0.96

1.1

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.80

0.96

1.1

89.16

42.64

u/ml

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

603

0.77

0.96

1.6

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.74

0.96

1.1

—

(3002256) Pathology report gross observation

233

2586

0.89

0.94

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

133

1.51

0.94

1.5

1.1

55.22

40.09

mg/l

0.25

110

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

125

1.52

0.93

1.9

1.4

20.00

16.75

u/ml

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

117

1.54

0.93

1.3

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.82

0.92

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

851

0.82

0.91

1.5

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

244

1.36

0.90

1.2

1.3

2.92

3.46

u/ml

0.27

112

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

340

1.30

0.90

1.3

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.69

0.88

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.69

0.88

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.79

0.87

1.0

1.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

158

1393

1.14

0.87

3.0

2.5

68.17

67.61

ml/min/173m2

0.06

581

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.58

0.87

1.1

1.0

1.07

1.17

u/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

120

1038

1.16

0.86

1.7

—

(3036489) Thrombin time

595

1.22

0.86

3.0

1.9

22.58

20.54

0.63

524

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

120

1.50

0.85

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

120

1.50

0.85

1.3

1.1

—

(3005033) Fetal Nuchal fold Thickness US

568

0.79

0.84

1.4

1.5

1.27

0.03

412

(3000330) Specific gravity of Urine by Test strip

110

948

1.17

0.83

3.4

3.1

1.02

ratio

0.82

845

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1884

18504

1.07

0.82

4.9

4.7

5.86

5.83

mmol/l

0.56

1787

16991

(40758558) Short blood count panel - Blood

580

5482

1.08

0.82

7.7

5.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

113

1.51

0.82

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

105

1.53

0.81

1.3

170.13

264.38

pmol/l

0.52

105

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.62

0.78

1.5

1.95

1.90

umol/l

0.14

(3004616) Nuclear Ab [Presence] in Serum

182

1.38

0.77

1.4

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

140

1.43

0.76

2.1

1.5

30.90

34.28

nmol/l

0.29

124

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

115

1.48

0.76

1.2

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

145

1286

1.14

0.76

1.2

—

(4034850) Laboratory test

569

1.20

0.74

6.3

9.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.64

0.73

8.9

3.4

1.06

1.19

—

(4268621) Lupus anticoagulant assay

168

1.37

0.71

2.0

2.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

134

1.42

0.71

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

114

1001

1.15

0.70

1.4

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

126

1.43

0.70

1.3

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

586

0.82

0.70

1.4

1.6

—

(3044007) Cell count panel - Peritoneal fluid

1.71

0.70

1.1

1.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2106

20807

1.08

0.69

22.5

15.1

77.27

75.58

umol/l

1.45

2091

20503

(40761536) Microorganisms panel - Urine sediment

133

1492

0.89

0.69

4.8

3.2

—

(40758292) HTLV I+II Ab panel - Serum

1.85

0.68

1.0

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

156

0.64

0.67

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

128

0.62

0.64

1.0

461.50

351.35

ng/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

129

0.62

0.63

1.0

59.59

46.26

ng/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

675

0.84

0.62

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.52

0.62

1.4

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.61

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

750

1.15

0.61

1.4

1.5

—

(40768800) Prostate Pathology biopsy report

356

0.78

0.60

1.2

—

(40768795) Lymph node Pathology biopsy report

163

0.67

0.60

1.5

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

175

1600

1.10

0.58

2.6

2.2

30.79

74.26

u/l

0.80

147

1329

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

310

1.23

0.57

1.0

1.1

1.73

1979.80

iu/ml

0.51

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.67

0.56

1.5

2.1

18.37

17.91

umol/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.56

1.4

1.2

—

(3004451) EKG impression Narrative

1.54

0.55

1.5

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

155

1414

1.10

0.55

1.9

2.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

782

0.87

0.54

1.1

1.55

1.54

g/l

0.10

782

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.48

0.53

1.6

2.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

125

1.36

0.53

1.5

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

577

0.85

0.53

1.4

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

169

1.30

0.53

1.0

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.54

0.53

1.0

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

181

0.72

0.52

3.0

1.9

34.14

25.78

mg/l

—

(3000093) Morphology [Interpretation] in Blood Narrative

143

1.33

0.52

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.45

0.51

1.1

1.2

9.17

9.41

mm/h

0.03

(3045142) Bone marrow Pathology biopsy report

179

1.29

0.51

1.2

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

109

1.38

0.50

2.2

2.6

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

1.46

0.50

1.8

1.0

54.50

61.81

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.46

0.50

1.2

1.1

—

7.67

—

(3032773) Endomysium IgG Ab [Titer] in Serum

189

1.27

0.49

1.0

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

850

1.12

0.49

5.0

2.5

1.44

1.20

0.96

841

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.56

0.49

1.0

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.56

0.49

1.0

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

1.45

0.48

1.5

29.36

29.25

umol/l

0.01

(3000963) Hemoglobin [Mass/volume] in Blood

2154

21706

0.94

0.47

27.3

18.1

135.39

135.14

g/l

0.34

2143

21427

(3034426) Prothrombin time (PT)

1.49

0.47

1.4

1.2

26.43

28.38

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.49

0.47

1.0

1.8

42.29

102.58

nmol/24h

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

358

3401

1.06

0.47

1.7

—

(21494434) Karyotype in Bone marrow

137

1.32

0.47

1.6

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.46

0.46

1.9

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

476

1.16

0.46

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

267

2515

1.07

0.46

1.7

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.43

0.46

1.0

1.3

—

(4195642) Thrombophilia screening test

237

1.23

0.45

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.40

0.45

2.0

1.3

7.45

9.15

ug/l

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

112

1.34

0.44

4.9

3.1

—

(3051651) Icteric interference index of Serum or Plasma

1.45

0.44

3.4

3.7

0.70

1.14

index

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.45

0.44

1.5

1.1

—

(40768793) Breast Pathology biopsy report

477

0.86

0.41

1.3

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

323

1.18

0.41

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

323

1.18

0.41

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.41

0.0

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2155

21698

0.95

0.41

27.5

18.2

42.75

40.45

0.58

2141

21400

(3026361) Erythrocytes [#/volume] in Blood

2155

21698

0.95

0.41

27.1

18.0

4.51

4.49

e12/l

1.20

2128

21098

(44816559) Phosphatidylethanol [Mass/volume] in Blood

719

1.12

0.41

1.6

1.5

0.28

0.32

mg/l

0.35

310

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(3010813) Leukocytes [#/volume] in Blood

2156

21706

0.95

0.40

27.1

18.0

7.18

6.54

e9/l

23.15

2129

21099

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.47

0.40

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

1.47

0.40

5.6

7.1

8.00

8.60

mmol/l

—

(3048879) Bone marrow aspiration report

1.47

0.40

1.0

1.4

—

(3035941) MCH [Entitic mass]

2155

21696

0.95

0.40

27.0

17.9

30.17

30.27

1.71

2142

21410

(3025468) Yersinia sp identified in Specimen by Organism specific culture

177

1.24

0.40

1.2

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2155

21695

0.95

0.40

27.0

17.9

90.92

90.80

0.58

2142

21407

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

115

1.31

0.38

1.3

2.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

466

1.14

0.38

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.39

0.38

5.0

3.0

4.20

1049.72

ug/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

429

1.14

0.38

3.5

3.7

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

684

0.89

0.38

1.4

1.5

1.17

1.24

ratio

0.18

402

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

684

0.89

0.38

1.4

1.5

0.88

0.95

ratio

0.68

398

(3006653) Thiamine [Moles/volume] in Blood

1.35

0.37

1.0

1.1

152.32

131.10

nmol/l

0.96

(3037121) Protein [Mass/volume] in Urine

581

1.12

0.37

3.9

2.7

217.08

260.35

mg/l

0.38

235

(3007461) Platelets [#/volume] in Blood

2155

21688

0.95

0.37

27.1

18.0

264.39

250.64

e9/l

17.09

2129

21159

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

683

0.89

0.37

1.4

1.5

1.17

1.19

ratio

0.05

397

(4146454) Self-monitoring of blood glucose

191

0.78

0.36

2.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.27

0.36

1.8

2.0

—

165.53

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

180

1.22

0.35

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

180

1.22

0.35

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

263

1.18

0.35

1.2

1.1

—

(4133840) Spirometry

1.43

0.35

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

427

0.86

0.35

3.2

2.9

3.32

1.73

index

0.55

195

(3044640) Blood type and Crossmatch panel - Blood

625

6074

1.04

0.34

2.6

2.1

—

(3023410) Appearance of Cerebral spinal fluid

173

1.22

0.32

1.4

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

302

3146

0.95

0.31

3.1

3.3

0.75

0.85

ug/l

1.12

185

2052

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.31

0.31

1.0

1.2

—

(36660697) Celiac disease serology panel - Serum

166

1568

1.06

0.30

1.1

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

106

0.75

0.29

1.4

—

(3025130) Human papilloma virus identified in Specimen

334

0.87

0.28

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1822

18062

1.03

0.28

4.1

3.9

1.32

1.23

mmol/l

5.08

1732

16722

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

121

1.24

0.28

1.1

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

637

0.91

0.28

2.7

3.2

44.98

924.51

u/ml

1.84

546

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.27

0.27

1.3

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.25

0.27

1.3

1.1

—

(3019225) pH of Specimen

172

1634

1.06

0.27

3.4

3.5

7.38

7.35

4.34

132

1141

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

470

4569

1.04

0.27

2.5

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

271

1.15

0.27

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

122

1.23

0.27

1.3

1.2

—

66.80

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.21

0.26

1.0

1.1

—

(4198724) Urine methamphetamine measurement

1.25

0.25

5.3

1.7

—

(3020650) Glucose [Presence] in Urine

1.23

0.25

1.6

1.8

0.00

0.04

estimate

—

(3022621) pH of Urine by Test strip

161

1535

1.05

0.23

2.7

2.6

6.00

6.10

0.83

116

1023

(3016018) Differential panel - Cerebral spinal fluid

181

1.16

0.22

1.2

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2078

20670

1.03

0.22

12.4

9.7

28.27

25.25

u/l

2.12

2045

19977

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

107

1.22

0.21

1.1

1419.31

1482.88

miu/ml

0.09

107

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

336

3456

0.97

0.21

1.5

—

(3024316) Viscosity of Plasma

0.00

0.21

0.0

1.1

—

1.35

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.21

0.0

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.21

0.0

2.1

—

1999.18

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

304

0.89

0.21

1.3

1.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.21

0.0

1.2

—

(3019174) dRVVT (LA screen)

0.00

0.21

0.0

1.2

—

(40765096) Chromosome analysis panel by Banding

1.16

0.21

1.0

1.1

—

(40768446) Kidney Pathology biopsy report

1.25

0.20

1.3

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

386

0.91

0.20

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

111

0.81

0.20

2.4

1.6

111.67

107.67

ng/l

—

111

(3033658) Prothrombin time (PT) actual/Normal

433

4427

0.97

0.19

4.3

3.3

91.92

90.15

0.73

423

4324

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.18

0.19

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

241

1.12

0.19

2.6

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.11

0.17

1.6

2.0

—

(3044927) Protein electrophoresis panel - Urine

148

1.15

0.16

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

381

0.92

0.16

4.5

3.2

26.53

28.09

mg/l

0.09

259

(3029396) Erythrocyte agglutination [Presence] in Blood

1.14

0.16

3.1

3.2

—

(3017704) Immunofixation for Urine

1.10

0.15

1.1

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.77

0.15

1.0

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

850

1.05

0.14

5.1

2.5

0.59

0.62

0.56

843

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

597

1.06

0.13

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

141

1.14

0.13

1.5

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

411

4181

0.98

0.13

4.4

4.7

22.01

22.50

0.25

180

2115

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

170

0.88

0.13

1.3

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1944

19511

0.98

0.13

5.3

2.67

2.73

mmol/l

2.47

1858

18224

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

182

1770

1.03

0.13

3.4

2.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

106

0.85

0.13

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

105

1.14

0.11

1.3

1.5

0.53

e9/l

0.01

105

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.15

0.10

1.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.11

0.09

1.0

1.3

95.40

76.09

ug/l

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

340

1.06

0.09

1.3

1.4

0.29

0.37

nmol/l

0.53

267

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.79

0.08

1.6

1.7

41.28

41.00

g/l

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.77

0.08

9.0

4.2

7.13

8.99

mg/l

—

(3047189) Immunofixation for 24 hour Urine

1.04

0.08

1.4

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

727

1.03

0.07

1.3

1.5

62.80

59.60

ug/l

0.25

617

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

749

1.03

0.06

1.6

1.4

3.64

3.19

mg/l

0.23

519

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

158

1.08

0.06

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1907

19100

0.99

0.05

4.7

4.6

1.48

1.49

mmol/l

0.57

1828

17824

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1921

19238

0.99

0.05

4.8

4.7

4.60

4.66

mmol/l

1.69

1843

18054

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

109

1071

1.02

0.05

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

262

0.95

0.04

1.6

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

219

1.05

0.04

1.5

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

703

0.98

0.03

1.3

162.65

217.40

miu/ml

1.07

326

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

597

0.99

0.01

2.0

1.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

299

2998

1.00

0.01

3.3

2.6

2.30

1.31

e6/l

0.35

166

1564

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

886

0.99

0.00

2.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

105

0.95

0.00

1.3

1.4

36.08

25.75

umol/l

—

(3026470) Cobalt [Mass/volume] in Blood

105

0.95

0.00

1.6

2.2

1.55

3.13

ug/l

—

100

(3020876) Protein [Mass/time] in 24 hour Urine

178

1.01

0.00

2.5

2.1

0.84

1.24

g/24h

0.53

102

(3051611) Lipemic interference index of Serum or Plasma

155

1.03

0.00

2.9

3.1

14.30

12.04

index

—

(3008295) Osmolality of Serum or Plasma

172

0.99

0.00

1.5

1.4

279.18

276.40

mosm/kgh2o

0.15

133

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

299

1.00

0.00

3.1

2.9

32.08

28.01

u/ml

0.12

289

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

518

5182

1.00

0.00

5.2

5.7

2.92

4.30

ug/l

0.83

474

4666

(4024509) Urine culture

879

1.00

0.00

2.0

1.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

115

1.04

0.00

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

6.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.87

0.00

4.0

2.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.92

-0.00

3.3

2.9

53.23

52.62

umol/l

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.00

-0.00

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.2

—

6.60

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

318.38

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.7

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

313.60

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

1.44

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.92

-0.00

1.6

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.12

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.4

—

3.11

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

30.06

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ASTHMA_MIXED – Asthma mixed form (mode)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Asthma mixed form (mode)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Asthma mixed form (mode) (ASTHMA_MIXED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints